Professional Documents
Culture Documents
Patient
Sherry R Allison
Date of birth
September 8, 1938
Sex
Female
Race(s)
Ethnicity
Language(s)
White
Not Hispanic or Latino
English (Preferred)
Contact info
Document Id
88be96c8-de90-4bcf-9b02-6cba82315349 1.3.6.1.4.1.21367.2008.1.2.100
Document Created:
Performer
Performer
Performer
Performer
Performer
Performer
Performer
Performer
Author
Rosetta v5.8.0.106
Contact info
Personal relationship
John F Allison
{$code/@code='SPS'?}
Contact info
Informant
Contact info
Legal authenticator
NextGen Admin of Masland Associates Inc signed at September 23, 2014, 09:47:35 -0400
Contact info
Document maintained by
Contact info
Table of Contents
Reaction
Severity
Status
Carbapenems
Unknown
Active
Cephalosporins
Unknown
Active
niacin
Unknown
Active
penicillin G
Unknown
Active
ESCITALOPRAM OXALATE
Unknown
Active
phenytoin
Unknown
Active
Medications
Medication
Instructions
Dosage
Status
88 MCG
Mar-19-2014 -
Active
30 MG
Mar-14-2014 -
Active
Feb-14-2014 -
Active
12.5 MG
Jan-20-2014 -
Active
warfarin 3 mg Tab
3 MG
Jan-20-2014 -
Active
warfarin 5 mg Tab
5 MG
Jan-20-2014 -
Active
500 MG
Jan-03-2014 -
Active
Lipitor 20 mg Tab
Jan-03-2014 -
Active
Aug-13-2013 -
Active
take (17G) by oral route every day mixed with 8 oz. water, juice, soda, coffee or tea
as needed
Aug-13-2013 -
Active
Oct-18-2012 -
Active
Jul-12-2012 -
Active
aspirin 81 mg Tab
81 MG
Dec-27-2011 -
Active
Feb-08-2008 -
Active
Active
Apr-14-2014 - Apr-182014
No Longer
Active
Dec-27-2013 - Apr-232014
No Longer
Active
30 MG
Apr-11-2013 - Mar-142014
No Longer
Active
88 MCG
Apr-10-2013 - Apr-102013
No Longer
Active
88 MCG
Apr-10-2013 - Mar-192014
No Longer
Active
30 MG
Mar-12-2013 - Apr-112013
No Longer
Active
Feb-13-2013 - Feb-142014
No Longer
Active
Feb-12-2013 - Jun-092013
No Longer
Active
prednisone 10 mg tablet
30 MG
Feb-12-2013 - Feb-182013
No Longer
Active
Feb-12-2013 - Dec-272013
No Longer
Active
take 2 Tablet by Oral route every day for 1 day then 1 tablet daily for 4 days.
Feb-12-2013 - Feb-162013
No Longer
Active
Feb-12-2013 - Feb-132013
No Longer
Active
12.5 MG
Jan-11-2013 - Jan-112013
No Longer
Active
12.5 MG
Jan-11-2013 - Jan-202014
No Longer
Active
Comments
Lipitor 20 mg Tab
warfarin 3 mg Tab
500 MG
Jan-08-2013 - Jan-032014
No Longer
Active
Jan-08-2013 - Jan-032014
No Longer
Active
Nov-15-2012 - Feb-122013
No Longer
Active
3 MG
Nov-15-2012 - Jan-202014
No Longer
Active
warfarin 5 mg Tab
5 MG
Nov-15-2012 - Nov-152012
No Longer
Active
warfarin 5 mg Tab
5 MG
Nov-15-2012 - Jan-202014
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-22-2012 - Nov-152012
No Longer
Active
Oct-18-2012 - Nov-152012
No Longer
Active
Oct-18-2012 - Feb-122013
No Longer
Active
Oct-18-2012 - Nov-152012
No Longer
Active
warfarin 5 mg Tab
5 MG
Sep-26-2012 - Nov-152012
No Longer
Active
warfarin 3 mg Tab
3 MG
Apr-27-2012 - Nov-152012
No Longer
Active
88 MCG
Apr-20-2012 - Apr-202012
No Longer
Active
88 MCG
Apr-20-2012 - Apr-102013
No Longer
Active
Mar-08-2012 - Nov-152012
No Longer
Active
100 MG
Mar-08-2012 - Apr-192013
No Longer
Active
12.5 MG
Feb-10-2012 - Jan-112013
No Longer
Active
12.5 MG
Feb-09-2012 - Feb-102012
No Longer
Active
500 MG
Jan-13-2012 - Jan-082013
No Longer
Active
Coumadin 1 mg Tab
take 1 tablet (1MG) by ORAL route every day or as directed alternating with 2mg
Jan-12-2012 - May-302012
No Longer
Active
Jan-12-2012 - Apr-202012
No Longer
Active
Jan-12-2012 - Oct-182012
No Longer
Active
200 MG
Jan-12-2012 - Mar-082012
No Longer
Active
500 MG
Jan-06-2012 - Jan-122012
No Longer
Active
Lipitor 20 mg Tab
Jan-06-2012 - Jan-082013
No Longer
Active
Lasix 40 mg Tab
40 MG
Dec-27-2011 - Jan-122012
No Longer
Active
take 1 packet (20MEQ) by oral route 4 times every day dissolved in 4-6 ounces of
20 MEQ
Dec-27-2011 - Jan-12-
No Longer
88 MCG
2012
Active
12.5 MG
Dec-27-2011 - Feb-092012
No Longer
Active
500 MG
Dec-27-2011 - Jan-092012
No Longer
Active
500 MG
Dec-27-2011 - Jan-062012
No Longer
Active
500 MG
Dec-27-2011 - Jan-092012
No Longer
Active
Align 4 mg Cap
Dec-27-2011 - Mar-082012
No Longer
Active
Dec-09-2011 - Jan-132012
No Longer
Active
Dec-09-2011 - Dec-272011
No Longer
Active
Dec-06-2011 - Dec-272011
No Longer
Active
Dec-06-2011 - Dec-092011
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-25-2011 - Jan-122012
No Longer
Active
Aug-26-2011 - Nov-272011
No Longer
Active
Coumadin 4 mg Tab
Feb-24-2011 - Jan-122012
No Longer
Active
Feb-24-2011 - Jan-122012
No Longer
Active
Jan-07-2011 - Apr-102011
No Longer
Active
Lipitor 20 mg Tab
Jan-07-2011 - Jan-062012
No Longer
Active
monthly
Jan-07-2011 - Nov-172011
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Nov-03-2010 - Oct-252011
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Sep-30-2010 - Nov-032010
No Longer
Active
promethazine 25 mg Tab
Sep-23-2010 - Sep-292010
No Longer
Active
1 tab bid
Jun-22-2010 - Sep-232010
No Longer
Active
May-26-2010 - Sep-232010
No Longer
Active
prednisone 10 mg Tab
3 day x 4days{30mg day} then 2 day x 6 days {20 mg day} then 1 day x 4
days{10mg day}
May-26-2010 - Sep-232010
No Longer
Active
Coumadin 4 mg Tab
Apr-12-2010 - Feb-242011
No Longer
Active
Apr-12-2010 - Feb-242011
No Longer
Active
Mar-23-2010 - Apr-122010
No Longer
Active
2 caps qd
Dec-14-2009 - Dec-062011
No Longer
Active
500 MG
200 MG
25 MG
1 tab bid
Dec-14-2009 - Jun-222010
No Longer
Active
monthly
Dec-14-2009 - Jan-072011
No Longer
Active
Lipitor 20 mg Tab
Dec-14-2009 - Jan-072011
No Longer
Active
Dec-14-2009 - Mar-232010
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Nov-02-2009 - Sep-302010
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-22-2009 - Oct-222009
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-22-2009 - Nov-022009
No Longer
Active
1 cap Mon,Fri
Jul-06-2009 - Apr-122010
No Longer
Active
Lyrica 50 mg Cap
Jun-08-2009 - Dec-142009
No Longer
Active
Coumadin 4 mg Tab
Apr-24-2009 - Apr-122010
No Longer
Active
Apr-24-2009 - Apr-122010
No Longer
Active
Lyrica 50 mg Cap
one tid
Mar-11-2009 - Jun-082009
No Longer
Active
Lyrica 50 mg Cap
one tid
Feb-12-2009 - Mar-112009
No Longer
Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-122009
No Longer
Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-122009
No Longer
Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-122009
No Longer
Active
monthly
Jan-12-2009 - Dec-142009
No Longer
Active
Lipitor 20 mg Tab
Dec-19-2008 - Dec-142009
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Dec-19-2008 - Oct-222009
No Longer
Active
1 tab bid
Dec-19-2008 - Dec-142009
No Longer
Active
Lyrica 50 mg Cap
one tid
Dec-19-2008 - Feb-122009
No Longer
Active
Lipitor 20 mg Tab
Nov-26-2008 - Dec-192008
No Longer
Active
Lyrica 50 mg Cap
one tid
Oct-29-2008 - Dec-192008
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-13-2008 - Dec-192008
No Longer
Active
Actonel 75 mg Tab
2 monthly
Sep-03-2008 - Jan-122009
No Longer
Active
Jul-31-2008 - Dec-142009
No Longer
Active
1 tab bid
Jul-30-2008 - Dec-19-
No Longer
2008
Active
Coumadin 4 mg Tab
May-12-2008 - Apr-242009
No Longer
Active
May-12-2008 - Apr-242009
No Longer
Active
Lyrica 50 mg Cap
one tid
May-12-2008 - Nov-262008
No Longer
Active
warfarin 2 mg Tab
as dir/4mg daily
Apr-04-2008 - Apr-042008
No Longer
Active
prn
Apr-04-2008 - Jan-122009
No Longer
Active
Coumadin 4 mg Tab
Apr-04-2008 - May-122008
No Longer
Active
Apr-04-2008 - May-122008
No Longer
Active
Lyrica 50 mg Cap
1 bid
Apr-04-2008 - Jul-312008
No Longer
Active
3 caps tid
Mar-20-2008 - Apr-042008
No Longer
Active
1 cap Mon-Wed-Fri
Feb-08-2008 - Jul-062009
No Longer
Active
2 bid
Dec-28-2007 - Mar-202008
No Longer
Active
warfarin 2 mg Tab
Nov-27-2007 - Apr-042008
No Longer
Active
Coumadin 4 mg Tab
Take as directed
Nov-27-2007 - Nov-272007
No Longer
Active
Lipitor 20 mg Tab
Nov-27-2007 - Nov-262008
No Longer
Active
use daily
Nov-27-2007 - Dec-282007
No Longer
Active
Actonel 35 mg Tab
Nov-15-2007 - Sep-032008
No Longer
Active
FOLTX 1-2.5-25MGTABLET
Oct-18-2007 - Oct-132008
No Longer
Active
warfarin 2 mg Tab
Oct-18-2007 - Nov-272007
No Longer
Active
Oct-03-2007 - Apr-042008
No Longer
Active
1 tab bid
Jul-11-2007 - Jul-30-2008
No Longer
Active
Lipitor 10 mg Tab
Jul-11-2007 - Nov-272007
No Longer
Active
Aricept 5 mg Tab
Jul-11-2007 - Jul-11-2007
No Longer
Active
Aricept 5 mg Tab
Jul-11-2007 - Nov-272007
No Longer
Active
Jul-11-2007 - Feb-082008
No Longer
Active
1 tab bid
Jun-28-2007 - Jul-112007
No Longer
Active
Jun-28-2007 - Nov-152007
No Longer
Active
Actonel 35 mg Tab
Lipitor 10 mg Tab
Jun-28-2007 - Jul-112007
No Longer
Active
Aricept 5 mg Tab
Jun-28-2007 - Jul-112007
No Longer
Active
Lipitor 10 mg Tab
May-29-2007 - Jun-282007
No Longer
Active
warfarin 2 mg Tab
May-29-2007 - Oct-182007
No Longer
Active
Apr-09-2007 - Apr-042008
No Longer
Active
Apr-09-2007 - Dec-062011
No Longer
Active
Apr-09-2007 - Jun-282007
No Longer
Active
Fosamax 70 mg Tab
Apr-09-2007 - Jun-282007
No Longer
Active
Apr-09-2007 - May-292007
No Longer
Active
Apr-09-2007 - May-292007
No Longer
Active
Lipitor 10 mg Tab
warfarin 2 mg Tab
Aricept 5 mg Tab
Apr-09-2007 - Jun-282007
No Longer
Active
Nexium 40 mg Cap
Apr-09-2007 - Feb-082008
No Longer
Active
Apr-09-2007 - Oct-032007
No Longer
Active
Problems
Condition
Sep-11-2014 -
PURE HYPERCHOLESTEROLEM
Aug-08-2014 -
Jul-24-2014 -
Jul-24-2014 -
Hypothyroidism
Jul-24-2014 -
Jul-24-2014 -
OVERWEIGHT
Jul-24-2014 -
Hypercholesterolemia
Jul-24-2014 -
Jul-24-2014 -
Jul-21-2014 -
PURE HYPERCHOLESTEROLEM
Jun-20-2014 -
Jun-20-2014 Jun-20-2014 -
Jun-12-2014 -
Jun-12-2014 -
Clinical Status
May-01-2014 -
Apr-17-2014 -
Bronchitis, Acute
Hypothyroidism
Dec-27-2013 -
Hypercholesterolemia
Dec-27-2013 -
OVERWEIGHT
Dec-27-2013 -
Dec-27-2013 -
Hypothyroidism
Aug-13-2013 -
Hypercholesterolemia
Aug-13-2013 -
OVERWEIGHT
Aug-13-2013 -
Aug-13-2013 -
Aug-13-2013 -
CONSTIPATION NOS
Apr-19-2013 -
Mar-12-2013 -
OVERWEIGHT
Mar-12-2013 -
Hypercholesterolemia
Mar-12-2013 -
Mar-12-2013 -
Mar-12-2013 -
CEREBRAL THROMBOSIS
Mar-12-2013 -
Asthma
Feb-12-2013 -
Bronchitis, Acute
Feb-12-2013 -
Feb-12-2013 -
Hypothyroidism
Nov-15-2012 -
Hypercholesterolemia
Nov-15-2012 -
Nov-15-2012 -
OVERWEIGHT
Nov-15-2012 -
Osteoporosis
Nov-15-2012 -
Oct-18-2012 -
Thrombocytopenia
Jul-12-2012 -
Hypothyroidism
Jul-12-2012 -
Hypercholesterolemia
Jul-12-2012 -
Jul-12-2012 -
Jul-12-2012 -
THROMBOCYTOPENIA NOS
May-30-2012 -
May-30-2012 -
MITRAL/AORTIC STENOSIS
May-30-2012 -
May-30-2012 -
May-30-2012 -
Apr-23-2012 -
Apr-23-2012 -
MITRAL/AORTIC STENOSIS
Apr-23-2012 -
Apr-23-2012 -
Mar-08-2012 -
PURE HYPERCHOLESTEROLEM
Mar-08-2012 -
MITRAL/AORTIC STENOSIS
Mar-08-2012 -
Mar-08-2012 -
OVERWEIGHT
Mar-08-2012 -
MITRAL/AORTIC STENOSIS
Jan-12-2012 -
HYPOTHYROIDISM NOS
Jan-12-2012 -
Jan-12-2012 -
Jan-12-2012 -
MITRAL/AORTIC STENOSIS
Dec-27-2011 -
Dec-27-2011 -
Dec-27-2011 -
HYPOTHYROIDISM NOS
Dec-27-2011 -
MITRAL/AORTIC STENOSIS
Dec-23-2011 -
MITRAL/AORTIC STENOSIS
Nov-17-2011 -
EPILEPSY
Nov-17-2011 -
Nov-17-2011 -
MITRAL/AORTIC STENOSIS
Aug-26-2011 -
OVERWEIGHT
Aug-26-2011 -
PURE HYPERCHOLESTEROLEM
Aug-26-2011 -
ATHEROSCLEROSIS
Aug-26-2011 -
HYPOTHYROIDISM NOS
Aug-26-2011 -
MITRAL/AORTIC STENOSIS
Feb-24-2011 -
OVERWEIGHT
Feb-24-2011 -
PURE HYPERCHOLESTEROLEM
Feb-24-2011 -
EPILEPSY
Feb-24-2011 -
HYPOTHYROIDISM NOS
Feb-24-2011 -
OSTEOPOROSIS NOS
Feb-24-2011 -
MITRAL/AORTIC STENOSIS
Sep-30-2010 -
Sep-30-2010 -
OVERWEIGHT
Sep-30-2010 -
PURE HYPERCHOLESTEROLEM
Sep-30-2010 -
HYPOTHYROIDISM NOS
Sep-30-2010 -
SEBORRHEIC KERATOSIS
Sep-30-2010 -
Sep-23-2010 -
MITRAL/AORTIC STENOSIS
Apr-12-2010 -
OVERWEIGHT
Apr-12-2010 -
PURE HYPERCHOLESTEROLEM
Apr-12-2010 -
Apr-12-2010 -
HYPOTHYROIDISM NOS
Apr-12-2010 -
Apr-12-2010 -
ACTINIC KERATOSIS
Dec-14-2009 -
MITRAL/AORTIC STENOSIS
Dec-14-2009 -
OVERWEIGHT
Dec-14-2009 -
PURE HYPERCHOLESTEROLEM
Dec-14-2009 -
PURE HYPERGLYCERIDEMIA
Dec-14-2009 -
HYPOTHYROIDISM NOS
Dec-14-2009 -
MITRAL/AORTIC STENOSIS
Jun-08-2009 -
OVERWEIGHT
Jun-08-2009 -
PURE HYPERCHOLESTEROLEM
Jun-08-2009 -
Jun-08-2009 -
HYPOTHYROIDISM NOS
Jun-08-2009 -
Jun-08-2009 -
OSTEOPOROSIS NOS
Jun-08-2009 -
OVERWEIGHT
Jan-12-2009 -
MITRAL/AORTIC STENOSIS
Jan-12-2009 -
MITRAL/AORTIC STENOSIS
Jan-12-2009 -
OVERWEIGHT
Jan-12-2009 -
PURE HYPERCHOLESTEROLEM
Jan-12-2009 -
Jan-12-2009 -
PURE HYPERCHOLESTEROLEM
Sep-03-2008 -
Sep-03-2008 -
OSTEOPOROSIS NOS
Sep-03-2008 -
PURE HYPERGLYCERIDEMIA
Sep-03-2008 -
OVERWEIGHT
Sep-03-2008 -
OVERWEIGHT
Sep-03-2008 -
PURE HYPERGLYCERIDEMIA
May-12-2008 -
PURE HYPERCHOLESTEROLEM
May-12-2008 -
May-12-2008 -
May-12-2008 -
HYPOTHYROIDISM NOS
May-12-2008 -
Mar-20-2008 -
Mar-20-2008 -
BENIGN HYPERTENSION
Mar-20-2008 -
Dec-27-2013 -
Acute
Mar-23-2010 -
Acute
Oct-18-2012 -
Chronic
May-30-2012 -
Chronic
May-30-2012 -
Chronic
May-30-2012 -
Chronic
Apr-23-2012 -
Chronic
MITRAL/AORTIC STENOSIS
Apr-23-2012 -
Chronic
Apr-23-2012 -
Chronic
Apr-23-2012 -
Chronic
MITRAL/AORTIC STENOSIS
Mar-08-2012 -
Chronic
Mar-08-2012 -
Chronic
Mar-08-2012 -
Chronic
PURE HYPERCHOLESTEROLEM
Mar-08-2012 -
Chronic
Mar-08-2012 -
Chronic
MITRAL/AORTIC STENOSIS
Jan-12-2012 -
Chronic
Jan-12-2012 -
Chronic
Jan-12-2012 -
Chronic
HYPOTHYROIDISM NOS
Jan-12-2012 -
Chronic
MITRAL/AORTIC STENOSIS
Dec-27-2011 -
Chronic
Dec-27-2011 -
Chronic
HYPOTHYROIDISM NOS
Dec-27-2011 -
Chronic
MITRAL/AORTIC STENOSIS
Nov-17-2011 -
Chronic
Nov-17-2011 -
Chronic
EPILEPSY
Nov-17-2011 -
Chronic
MITRAL/AORTIC STENOSIS
Aug-26-2011 -
Chronic
OVERWEIGHT
Aug-26-2011 -
Chronic
PURE HYPERCHOLESTEROLEM
Aug-26-2011 -
Chronic
HYPOTHYROIDISM NOS
Aug-26-2011 -
Chronic
ATHEROSCLEROSIS
Aug-26-2011 -
Chronic
MITRAL/AORTIC STENOSIS
Feb-24-2011 -
Chronic
OVERWEIGHT
Feb-24-2011 -
Chronic
PURE HYPERCHOLESTEROLEM
Feb-24-2011 -
Chronic
HYPOTHYROIDISM NOS
Feb-24-2011 -
Chronic
OSTEOPOROSIS NOS
Feb-24-2011 -
Chronic
OVERWEIGHT
Sep-30-2010 -
Chronic
Sep-30-2010 -
Chronic
HYPOTHYROIDISM NOS
Sep-30-2010 -
Chronic
MITRAL/AORTIC STENOSIS
Apr-12-2010 -
Chronic
OVERWEIGHT
Apr-12-2010 -
Chronic
PURE HYPERCHOLESTEROLEM
Apr-12-2010 -
Chronic
Apr-12-2010 -
Chronic
MITRAL/AORTIC STENOSIS
Dec-14-2009 -
Chronic
OVERWEIGHT
Dec-14-2009 -
Chronic
PURE HYPERCHOLESTEROLEM
Dec-14-2009 -
Chronic
PURE HYPERGLYCERIDEMIA
Dec-14-2009 -
Chronic
HYPOTHYROIDISM NOS
Dec-14-2009 -
Chronic
MITRAL/AORTIC STENOSIS
Jun-08-2009 -
Chronic
OVERWEIGHT
Jun-08-2009 -
Chronic
Jun-08-2009 -
Chronic
PURE HYPERCHOLESTEROLEM
Jun-08-2009 -
Chronic
HYPOTHYROIDISM NOS
Jun-08-2009 -
Chronic
MITRAL/AORTIC STENOSIS
Jan-12-2009 -
Chronic
OVERWEIGHT
Jan-12-2009 -
Chronic
PURE HYPERCHOLESTEROLEM
Jan-12-2009 -
Chronic
Jan-12-2009 -
Chronic
Sep-03-2008 -
Chronic
PURE HYPERCHOLESTEROLEM
Sep-03-2008 -
Chronic
OSTEOPOROSIS NOS
Sep-03-2008 -
Chronic
HYPOTHYROIDISM NOS
May-12-2008 -
Chronic
May-12-2008 -
Chronic
PURE HYPERCHOLESTEROLEM
May-12-2008 -
Chronic
May-12-2008 -
Chronic
Jun-28-2007 -
Chronic
OSTEOPOROSIS NOS
Jun-28-2007 -
Chronic
HYPOTHYROIDISM NOS
Jun-28-2007 -
Chronic
PURE HYPERGLYCERIDEMIA
Jun-28-2007 -
Chronic
PRESENILE DEPRESSION
Jun-28-2007 -
Chronic
ATHEROSCLEROSIS
Jun-28-2007 -
Chronic
EPILEPSY
Jun-28-2007 -
Chronic
DEMENTIA
Jun-28-2007 -
Chronic
BACKACHE NOS
Jun-28-2007 -
Chronic
PURE HYPERCHOLESTEROLEM
Sep-30-2010 -
Controlled
HYPOTHYROIDISM NOS
Apr-12-2010 -
Controlled
Procedures
Procedure
Date
Sep-05-2014
Sep-02-2014
SGPT
Sep-02-2014
SGOT
Sep-02-2014
Alkaline phosphatase
Sep-02-2014
Total Bili
Sep-02-2014
BUN
Sep-02-2014
Creatinine
Sep-02-2014
Sed Rate
Sep-02-2014
CBC
Sep-02-2014
Prothrombin time
Sep-02-2014
Aug-05-2014
Prothrombin time
Aug-05-2014
Venipuncture
Aug-05-2014
Jul-24-2014
Jul-24-2014
Jul-24-2014
Jul-15-2014
Prothrombin time
Jul-15-2014
Venipuncture
Jul-15-2014
Jun-17-2014
TSH
Jun-17-2014
MET Profile
Jun-17-2014
Jun-17-2014
Prothrombin time
Jun-17-2014
Total Bili
Jun-17-2014
SGPT
Jun-17-2014
SGOT
Jun-17-2014
Alkaline phosphatase
Jun-17-2014
Albumin
Jun-17-2014
Jun-17-2014
Venipuncture
Jun-17-2014
CBC
Jun-17-2014
HDL Cholesterol
Jun-17-2014
Triglycerides
Jun-17-2014
Jun-12-2014
Jun-12-2014
May-27-2014
May-27-2014
Prothrombin time
May-27-2014
Venipuncture
May-27-2014
May-12-2014
Prothrombin time
May-12-2014
Venipuncture
May-12-2014
Apr-28-2014
Prothrombin time
Apr-28-2014
Venipuncture
Apr-28-2014
Apr-14-2014
BMI Reporting
Apr-14-2014
Apr-14-2014
Apr-14-2014
Prothrombin time
Apr-14-2014
Venipuncture
Apr-14-2014
Mar-18-2014
Prothrombin time
Mar-18-2014
Venipuncture
Mar-18-2014
Feb-17-2014
Prothrombin time
Feb-17-2014
Venipuncture
Feb-17-2014
Feb-04-2014
Venipuncture
Feb-04-2014
Prothrombin time
Feb-04-2014
Jan-06-2014
Prothrombin time
Jan-06-2014
Venipuncture
Jan-06-2014
Dec-27-2013
Dec-23-2013
Venipuncture
Dec-23-2013
Prothrombin time
Dec-23-2013
Dec-18-2013
Venipuncture
Dec-18-2013
Prothrombin time
Dec-18-2013
MET Profile
Dec-18-2013
CBC
Dec-18-2013
HDL Cholesterol
Dec-18-2013
Triglycerides
Dec-18-2013
TSH
Dec-18-2013
SGPT
Dec-18-2013
Nov-19-2013
Venipuncture
Nov-19-2013
Prothrombin time
Nov-19-2013
Oct-22-2013
Prothrombin time
Oct-22-2013
Venipuncture
Oct-22-2013
Fluvirin Vaccine
Sep-24-2013
Sep-24-2013
Venipuncture
Sep-24-2013
Prothrombin time
Sep-24-2013
Sep-03-2013
Prothrombin time
Sep-03-2013
Venipuncture
Sep-03-2013
Aug-13-2013
Aug-13-2013
Administration Of Injection
Aug-13-2013
Aug-13-2013
Aug-06-2013
Venipuncture
Aug-06-2013
Prothrombin time
Aug-06-2013
MET Profile
Aug-06-2013
CBC
Aug-06-2013
HDL Cholesterol
Aug-06-2013
Triglycerides
Aug-06-2013
TSH
Aug-06-2013
SGPT
Aug-06-2013
Jul-11-2013
Prothrombin time
Jul-11-2013
Venipuncture
Jul-11-2013
Jun-13-2013
Venipuncture
Jun-13-2013
Prothrombin time
Jun-13-2013
May-16-2013
Venipuncture
May-16-2013
Prothrombin time
May-16-2013
Apr-23-2013
Venipuncture
Apr-23-2013
Prothrombin time
Apr-23-2013
Apr-19-2013
Apr-19-2013
Apr-02-2013
CBC
Apr-02-2013
Prothrombin time
Apr-02-2013
TSH
Apr-02-2013
Urinalysis
Apr-02-2013
Venipuncture
Apr-02-2013
Mar-12-2013
Mar-12-2013
Venipuncture
Mar-12-2013
Prothrombin time
Mar-12-2013
Feb-21-2013
Venipuncture
Feb-21-2013
Prothrombin time
Feb-21-2013
MET Profile
Feb-21-2013
HDL Cholesterol
Feb-21-2013
Triglycerides
Feb-21-2013
SGPT
Feb-21-2013
Feb-12-2013
Peak Flow
Feb-12-2013
Feb-12-2013
Feb-12-2013
Feb-07-2013
Prothrombin time
Feb-07-2013
Venipuncture
Feb-07-2013
Dec-27-2012
Venipuncture
Dec-27-2012
Prothrombin time
Dec-27-2012
Dec-12-2012
T-DAP VACCINE>7IM
Dec-12-2012
Administration Of Injection
Dec-12-2012
Dec-06-2012
Venipuncture
Dec-06-2012
Prothrombin time
Dec-06-2012
Nov-15-2012
Fluvirin Vaccine
Nov-15-2012
Nov-15-2012
Venipuncture
Nov-15-2012
Prothrombin time
Nov-15-2012
Oct-23-2012
Venipuncture
Oct-23-2012
Prothrombin time
Oct-23-2012
HDL Cholesterol
Oct-23-2012
Triglycerides
Oct-23-2012
TSH
Oct-23-2012
Oct-18-2012
Oct-02-2012
Venipuncture
Oct-02-2012
Prothrombin time
Oct-02-2012
Sep-11-2012
Prothrombin time
Sep-11-2012
Venipuncture
Sep-11-2012
Aug-28-2012
Venipuncture
Aug-28-2012
Prothrombin time
Aug-28-2012
CBC
Aug-28-2012
Aug-14-2012
Venipuncture
Aug-14-2012
Prothrombin time
Aug-14-2012
CBC
Aug-14-2012
Jul-18-2012
Venipuncture
Jul-18-2012
Prothrombin time
Jul-18-2012
Jul-12-2012
Jun-28-2012
Venipuncture
Jun-28-2012
Prothrombin time
Jun-28-2012
TSH
Jun-28-2012
MET Profile
Jun-28-2012
HDL Cholesterol
Jun-28-2012
Triglycerides
Jun-28-2012
SGPT
Jun-28-2012
CBC
Jun-28-2012
Jun-13-2012
Prothrombin time
Jun-13-2012
Venipuncture
Jun-13-2012
May-30-2012
May-23-2012
Prothrombin time
May-23-2012
CBC
May-23-2012
Venipuncture
May-23-2012
May-02-2012
Prothrombin time
May-02-2012
Venipuncture
May-02-2012
Apr-23-2012
Apr-16-2012
Venipuncture
Apr-16-2012
Prothrombin time
Apr-16-2012
Apr-13-2012
CBC
Apr-13-2012
Prothrombin time
Apr-13-2012
Venipuncture
Apr-13-2012
MET Profile
Mar-23-2012
Mar-23-2012
Prothrombin time
Mar-23-2012
MET Profile
Mar-23-2012
Mar-08-2012
Mar-02-2012
MET Profile
Mar-02-2012
CBC
Mar-02-2012
HDL Cholesterol
Mar-02-2012
Triglycerides
Mar-02-2012
Prothrombin time
Mar-02-2012
SGPT
Mar-02-2012
Venipuncture
Mar-02-2012
Feb-10-2012
Venipuncture
Feb-10-2012
Prothrombin time
Feb-10-2012
free T4
Jan-19-2012
Prothrombin time
Jan-19-2012
TSH
Jan-19-2012
Venipuncture
Jan-19-2012
Venipuncture
Jan-12-2012
MET Profile
Jan-12-2012
Prothrombin time
Jan-12-2012
CBC
Jan-12-2012
Jan-12-2012
Jan-03-2012
Venipuncture
Jan-03-2012
Prothrombin time
Jan-03-2012
Venipuncture
Dec-27-2011
Prothrombin time
Dec-27-2011
MET Profile
Dec-27-2011
CBC
Dec-27-2011
Dec-27-2011
Dec-09-2011
Dec-06-2011
Venipuncture
Nov-23-2011
Nov-23-2011
Prothrombin time
Nov-23-2011
MET Profile
Nov-23-2011
Nov-17-2011
Nov-17-2011
Nov-02-2011
Venipuncture
Nov-02-2011
Prothrombin time
Nov-02-2011
Oct-11-2011
Venipuncture
Oct-11-2011
Prothrombin time
Oct-11-2011
Sep-21-2011
Venipuncture
Sep-21-2011
Prothrombin time
Sep-21-2011
Aug-31-2011
Venipuncture
Aug-31-2011
Prothrombin time
Aug-31-2011
CBC
Aug-31-2011
Sed Rate
Aug-31-2011
Aug-26-2011
Aug-26-2011
Aug-26-2011
Aug-10-2011
Venipuncture
Aug-10-2011
Prothrombin time
Aug-10-2011
Lipid profile
Aug-10-2011
MET Profile
Aug-10-2011
TSH
Aug-10-2011
SGOT
Aug-10-2011
Jul-20-2011
Prothrombin time
Jul-20-2011
Venipuncture
Jul-20-2011
Jul-01-2011
Venipuncture
Jul-01-2011
Prothrombin time
Jul-01-2011
Jun-10-2011
Venipuncture
Jun-10-2011
Prothrombin time
Jun-10-2011
May-25-2011
Venipuncture
May-25-2011
Prothrombin time
May-25-2011
May-04-2011
Venipuncture
May-04-2011
Prothrombin time
May-04-2011
Apr-13-2011
Venipuncture
Apr-13-2011
Prothrombin time
Apr-13-2011
Mar-23-2011
Venipuncture
Mar-23-2011
Prothrombin time
Mar-23-2011
Mar-02-2011
Prothrombin time
Mar-02-2011
Ferritin
Mar-02-2011
Urinalysis
Mar-02-2011
Venipuncture
Mar-02-2011
Feb-24-2011
Feb-09-2011
Prothrombin time
Feb-09-2011
MET Profile
Feb-09-2011
HDL Cholesterol
Feb-09-2011
Triglycerides
Feb-09-2011
TSH
Feb-09-2011
SGPT
Feb-09-2011
Venipuncture
Feb-09-2011
Jan-20-2011
Prothrombin time
Jan-20-2011
Venipuncture
Jan-20-2011
Dec-29-2010
Venipuncture
Dec-29-2010
Prothrombin time
Dec-29-2010
Dec-08-2010
Prothrombin time
Dec-08-2010
Venipuncture
Dec-08-2010
Nov-17-2010
Venipuncture
Nov-17-2010
Prothrombin time
Nov-17-2010
Oct-27-2010
Prothrombin time
Oct-27-2010
Venipuncture
Oct-27-2010
Oct-06-2010
Prothrombin time
Oct-06-2010
Venipuncture
Oct-06-2010
Sep-30-2010
Sep-30-2010
Administration Of Injection
Sep-30-2010
Sep-23-2010
Sep-15-2010
Prothrombin time
Sep-15-2010
Venipuncture
Sep-15-2010
Aug-24-2010
Prothrombin time
Aug-24-2010
MET Profile
Aug-24-2010
CBC
Aug-24-2010
HDL Cholesterol
Aug-24-2010
Triglycerides
Aug-24-2010
Sed Rate
Aug-24-2010
TSH
Aug-24-2010
Albumin
Aug-24-2010
SGOT
Aug-24-2010
SGPT
Aug-24-2010
Total Bili
Aug-24-2010
Alkaline phosphatase
Aug-24-2010
Venipuncture
Aug-24-2010
Aug-03-2010
Venipuncture
Aug-03-2010
Prothrombin time
Aug-03-2010
Jul-13-2010
Prothrombin time
Jul-13-2010
Venipuncture
Jul-13-2010
Jun-22-2010
Venipuncture
Jun-22-2010
Prothrombin time
Jun-22-2010
Jun-01-2010
Venipuncture
Jun-01-2010
Prothrombin time
Jun-01-2010
May-26-2010
May-24-2010
Venipuncture
May-24-2010
Prothrombin time
May-24-2010
May-13-2010
May-12-2010
Venipuncture
May-12-2010
Prothrombin time
May-12-2010
Apr-21-2010
Venipuncture
Apr-21-2010
Prothrombin time
Apr-21-2010
Apr-12-2010
Apr-12-2010
Apr-07-2010
Venipuncture
Apr-07-2010
Prothrombin time
Apr-07-2010
Mar-23-2010
Mar-17-2010
Venipuncture
Mar-17-2010
Prothrombin time
Mar-17-2010
Lipid profile
Mar-17-2010
MET Profile
Mar-17-2010
CBC
Mar-17-2010
Sed Rate
Mar-17-2010
TSH
Mar-17-2010
Albumin
Mar-17-2010
SGOT
Mar-17-2010
SGPT
Mar-17-2010
Total Bili
Mar-17-2010
Alkaline phosphatase
Mar-17-2010
Feb-24-2010
Venipuncture
Feb-24-2010
Prothrombin time
Feb-24-2010
Feb-03-2010
Venipuncture
Feb-03-2010
Prothrombin time
Feb-03-2010
Jan-13-2010
Venipuncture
Jan-13-2010
Prothrombin time
Jan-13-2010
Dec-23-2009
Prothrombin time
Dec-23-2009
Venipuncture
Dec-23-2009
Dec-14-2009
Dec-14-2009
Dec-03-2009
Venipuncture
Dec-03-2009
Prothrombin time
Dec-03-2009
MET Profile
Dec-03-2009
HDL Cholesterol
Dec-03-2009
Triglycerides
Dec-03-2009
TSH
Dec-03-2009
SGPT
Dec-03-2009
Nov-12-2009
Venipuncture
Nov-12-2009
Prothrombin time
Nov-12-2009
Oct-23-2009
Venipuncture
Oct-23-2009
Prothrombin time
Oct-23-2009
Oct-01-2009
Venipuncture
Oct-01-2009
Prothrombin time
Oct-01-2009
Sep-10-2009
Venipuncture
Sep-10-2009
Prothrombin time
Sep-10-2009
Aug-27-2009
Venipuncture
Aug-27-2009
Prothrombin time
Aug-27-2009
Aug-06-2009
Venipuncture
Aug-06-2009
Prothrombin time
Aug-06-2009
Jul-16-2009
Venipuncture
Jul-16-2009
CBC
Jul-16-2009
Prothrombin time
Jul-16-2009
Sed Rate
Jul-16-2009
Jul-06-2009
Venipuncture
Jun-26-2009
CBC
Jun-26-2009
Jun-25-2009
Venipuncture
Jun-25-2009
Prothrombin time
Jun-25-2009
Jun-25-2009
Jun-08-2009
Jun-08-2009
CBC
Jun-08-2009
Prothrombin time
Jun-08-2009
Venipuncture
Jun-08-2009
May-18-2009
Prothrombin time
May-18-2009
Lipid profile
May-18-2009
MET Profile
May-18-2009
TSH
May-18-2009
Urinalysis
May-18-2009
SGPT
May-18-2009
Venipuncture
May-18-2009
Apr-27-2009
Prothrombin time
Apr-27-2009
Venipuncture
Apr-27-2009
Apr-06-2009
Prothrombin time
Apr-06-2009
Venipuncture
Apr-06-2009
Mar-16-2009
Prothrombin time
Mar-16-2009
Venipuncture
Mar-16-2009
Feb-23-2009
Prothrombin time
Feb-23-2009
Venipuncture
Feb-23-2009
Feb-02-2009
Prothrombin time
Feb-02-2009
Venipuncture
Feb-02-2009
Jan-12-2009
Prothrombin time
Jan-12-2009
Venipuncture
Jan-12-2009
Dec-22-2008
Prothrombin time
Dec-22-2008
MET Profile
Dec-22-2008
CBC
Dec-22-2008
HDL Cholesterol
Dec-22-2008
Triglycerides
Dec-22-2008
SGPT
Dec-22-2008
Venipuncture
Dec-22-2008
Dec-01-2008
Prothrombin time
Dec-01-2008
Venipuncture
Dec-01-2008
Nov-17-2008
Prothrombin time
Nov-17-2008
Venipuncture
Nov-17-2008
Oct-27-2008
Prothrombin time
Oct-27-2008
Venipuncture
Oct-27-2008
Oct-13-2008
Prothrombin time
Oct-13-2008
Venipuncture
Oct-13-2008
Echocardiogram
Oct-13-2008
Oct-13-2008
Oct-13-2008
Oct-13-2008
Oct-13-2008
Sep-24-2008
Prothrombin time
Sep-24-2008
Venipuncture
Sep-24-2008
Sep-03-2008
Prothrombin time
Sep-03-2008
Venipuncture
Sep-03-2008
Venipuncture
Aug-22-2008
Aug-18-2008
Prothrombin time
Aug-18-2008
HDL Cholesterol
Aug-18-2008
Triglycerides
Aug-18-2008
MET Profile
Aug-18-2008
Venipuncture
Aug-18-2008
Aug-15-2008
CBC
Aug-04-2008
SGOT
Aug-04-2008
SGPT
Aug-04-2008
Total Bili
Aug-04-2008
Alkaline phosphatase
Aug-04-2008
Creatinine
Aug-04-2008
Sed Rate
Aug-04-2008
Calcium Serum
Aug-04-2008
Venipuncture
Aug-04-2008
Jul-31-2008
Jul-14-2008
Prothrombin time
Jul-14-2008
Venipuncture
Jul-14-2008
Jun-23-2008
Prothrombin time
Jun-23-2008
Venipuncture
Jun-23-2008
Jun-02-2008
Prothrombin time
Jun-02-2008
Venipuncture
Jun-02-2008
May-12-2008
Prothrombin time
May-12-2008
Venipuncture
May-12-2008
May-07-2008
Apr-25-2008
Prothrombin time
Apr-25-2008
CBC
Apr-25-2008
SGPT
Apr-25-2008
Triglycerides
Apr-25-2008
TSH
Apr-25-2008
HDL Cholesterol
Apr-25-2008
MET Profile
Apr-25-2008
Venipuncture
Apr-25-2008
Apr-04-2008
Prothrombin time
Apr-04-2008
Venipuncture
Apr-04-2008
Mar-20-2008
Mar-11-2008
Prothrombin time
Mar-11-2008
Venipuncture
Mar-11-2008
Feb-18-2008
Prothrombin time
Feb-18-2008
Venipuncture
Feb-18-2008
Feb-08-2008
Feb-08-2008
Jan-25-2008
Prothrombin time
Jan-25-2008
Venipuncture
Jan-25-2008
Jan-04-2008
Prothrombin time
Jan-04-2008
Venipuncture
Jan-04-2008
Dec-28-2007
Dec-11-2007
Prothrombin time
Dec-11-2007
Nov-27-2007
Nov-20-2007
Prothrombin time
Nov-20-2007
CBC
Nov-20-2007
SGPT
Nov-20-2007
Triglycerides
Nov-20-2007
TSH
Nov-20-2007
HDL Cholesterol
Nov-20-2007
MET Profile
Nov-20-2007
Venipuncture
Nov-20-2007
Oct-29-2007
Prothrombin time
Oct-29-2007
Venipuncture
Oct-29-2007
Oct-25-2007
Oct-25-2007
Oct-08-2007
Prothrombin time
Oct-08-2007
Venipuncture
Oct-08-2007
Sep-17-2007
Prothrombin time
Sep-17-2007
Venipuncture
Sep-17-2007
Aug-23-2007
Urinalysis
Aug-23-2007
Prothrombin time
Aug-23-2007
Venipuncture
Aug-23-2007
Aug-06-2007
Prothrombin time
Aug-06-2007
Venipuncture
Aug-06-2007
Jul-16-2007
Prothrombin time
Jul-16-2007
Venipuncture
Jul-16-2007
Jun-28-2007
Jun-25-2007
Prothrombin time
Jun-25-2007
CBC
Jun-25-2007
SGPT
Jun-25-2007
Triglycerides
Jun-25-2007
HDL Cholesterol
Jun-25-2007
MET Profile
Jun-25-2007
Venipuncture
Jun-25-2007
Jun-04-2007
Prothrombin time
Jun-04-2007
Venipuncture
Jun-04-2007
May-21-2007
Prothrombin time
May-21-2007
Venipuncture
May-21-2007
May-07-2007
Prothrombin time
May-07-2007
Venipuncture
May-07-2007
Apr-23-2007
Prothrombin time
Apr-23-2007
Venipuncture
Apr-23-2007
Apr-09-2007
Mar-30-2007
Prothrombin time
Mar-30-2007
Venipuncture
Mar-30-2007
Mar-26-2007
Prothrombin time
Mar-26-2007
Venipuncture
Mar-26-2007
Mar-23-2007
Prothrombin time
Mar-23-2007
Venipuncture
Mar-23-2007
Mar-15-2007
Prothrombin time
Mar-15-2007
Venipuncture
Mar-15-2007
Feb-28-2007
CBC
Feb-28-2007
MET Profile
Feb-28-2007
Venipuncture
Feb-28-2007
Feb-28-2007
Feb-09-2007
Prothrombin time
Feb-09-2007
Venipuncture
Feb-09-2007
Jan-30-2007
Jan-22-2007
Prothrombin time
Jan-22-2007
TSH
Jan-22-2007
free T4
Jan-22-2007
Venipuncture
Jan-22-2007
Jan-05-2007
Jan-02-2007
Prothrombin time
Jan-02-2007
Venipuncture
Jan-02-2007
Dec-11-2006
Prothrombin time
Dec-11-2006
Venipuncture
Dec-11-2006
Nov-20-2006
Prothrombin time
Nov-20-2006
Venipuncture
Nov-20-2006
Oct-30-2006
Prothrombin time
Oct-30-2006
Venipuncture
Oct-30-2006
Oct-23-2006
Oct-23-2006
Oct-23-2006
Oct-09-2006
Prothrombin time
Oct-09-2006
SGPT
Oct-09-2006
Triglycerides
Oct-09-2006
HDL Cholesterol
Oct-09-2006
MET Profile
Oct-09-2006
Venipuncture
Oct-09-2006
Sep-25-2006
Sep-22-2006
Sep-18-2006
Prothrombin time
Sep-18-2006
Venipuncture
Sep-18-2006
Sep-14-2006
Kenalog 10 MG
Sep-14-2006
Sep-01-2006
Urinalysis
Sep-01-2006
Aug-28-2006
Prothrombin time
Aug-28-2006
CBC
Aug-28-2006
Sed Rate
Aug-28-2006
Venipuncture
Aug-28-2006
Aug-07-2006
Prothrombin time
Aug-07-2006
Venipuncture
Aug-07-2006
Jul-25-2006
Jul-17-2006
Prothrombin time
Jul-17-2006
Sed Rate
Jul-17-2006
SGPT
Jul-17-2006
TSH
Jul-17-2006
Urinalysis
Jul-17-2006
HDL Cholesterol
Jul-17-2006
Comprehensive Profile
Jul-17-2006
Venipuncture
Jul-17-2006
Triglycerides
Jul-17-2006
Jun-26-2006
Prothrombin time
Jun-26-2006
Venipuncture
Jun-26-2006
Jun-19-2006
Prothrombin time
Jun-19-2006
Venipuncture
Jun-19-2006
Jun-05-2006
Prothrombin time
Jun-05-2006
Venipuncture
Jun-05-2006
May-23-2006
May-22-2006
Prothrombin time
May-22-2006
Venipuncture
May-22-2006
May-15-2006
Prothrombin time
May-15-2006
Venipuncture
May-15-2006
May-08-2006
Prothrombin time
May-08-2006
CBC
May-08-2006
MET Profile
May-08-2006
Venipuncture
May-08-2006
May-01-2006
Apr-24-2006
Prothrombin time
Apr-24-2006
Venipuncture
Apr-24-2006
Apr-21-2006
Prothrombin time
Apr-21-2006
Venipuncture
Apr-21-2006
Apr-14-2006
Prothrombin time
Apr-14-2006
Venipuncture
Apr-14-2006
Mar-13-2006
Alkaline phosphatase
Mar-09-2006
SGOT
Mar-09-2006
SGPT
Mar-09-2006
Total Bili
Mar-09-2006
Venipuncture
Mar-09-2006
Mar-01-2006
Prothrombin time
Mar-01-2006
Venipuncture
Mar-01-2006
Feb-23-2006
Urinalysis
Feb-23-2006
Feb-22-2006
Prothrombin time
Feb-22-2006
Venipuncture
Feb-22-2006
Feb-17-2006
Prothrombin time
Feb-17-2006
Venipuncture
Feb-17-2006
Feb-16-2006
Prothrombin time
Feb-16-2006
Venipuncture
Feb-16-2006
Feb-15-2006
CBC
Feb-15-2006
Prothrombin time
Feb-15-2006
Sed Rate
Feb-15-2006
Triglycerides
Feb-15-2006
TSH
Feb-15-2006
Urinalysis
Feb-15-2006
HDL Cholesterol
Feb-15-2006
Comprehensive Profile
Feb-15-2006
MET Profile
Feb-15-2006
Venipuncture
Feb-15-2006
Feb-15-2006
Electrocardiogram report
Feb-06-2006
Feb-13-2006
Feb-08-2006
Feb-07-2006
Feb-01-2006
Prothrombin time
Feb-01-2006
Venipuncture
Feb-01-2006
Jan-25-2006
Prothrombin time
Jan-25-2006
Venipuncture
Jan-25-2006
Jan-20-2006
Results
Test Name
Date
and
Time
Measure
Units
Reference
Range
Abnormal
Flag
Negative
Comments
Sep-05Positive
2014
15:06:41
Sep-0221.3
2014
09:53:10
sec
INR
Sep-021.9
2014
09:53:10
Ratio
Sep-0228
2014
09:53:10
U/L
9-60
Sep-0232
2014
09:53:10
U/L
10-35
Sep-0299
2014
09:53:10
U/L
40-115
Sep-020.6
2014
09:53:10
mg/dL
0.2-1.2
Sep-024.2
2014
09:53:10
g/dL
3.6-5.1
Sep-0216
2014
09:53:10
mg/dL
7-25
Sep-020.84
2014
09:53:10
mg/dL
0.50-1.20
Sep-0228
2014
09:53:10
mm/hr
0-20
Panel Description:
Sedimentation Rate
SR
Sep-027.9
2014
09:53:10
x10(3) K/uL
3.8-11.0
RBC
Sep-024.48
2014
09:53:10
x10(6) M/uL
3.40-5.30
HGB
Sep-0213.7
2014
09:53:10
g/dL
10.9-14.7
HCT
Sep-0242.2
2014
09:53:10
33.0-43.0
MCV
Sep-0294.2
2014
09:53:10
fl
80.0-96.0
MCH
Sep-0230.6
2014
09:53:10
pg
26.0-34.0
MCHC
Sep-0232.5
2014
09:53:10
g/dL
31.0-36.0
PLT
Sep-02149
2014
09:53:10
x10(3) K/uL
140-400
LYM%
Sep-0235.4
2014
09:53:10
15.0-50.0
MID%
Sep-0210.9
2014
09:53:10
0.1-24.0
GRAN%
Sep-0253.7
2014
09:53:10
40.0-80.0
LYM
Sep-022.8
2014
09:53:10
x10(3) K/uL
1.0-4.2
MID
Sep-020.9
2014
09:53:10
x10(3) K/uL
0.0-1.8
GRAN
Sep-024.2
2014
09:53:10
x10(3) K/uL
1.3-8.8
RDW
Sep-0213.0
2014
09:53:10
11.0-16.0
PT
Aug-05- 25.4
2014
11:12:40
sec
INR
Aug-05- 2.3
2014
11:12:40
Ratio
Jul-1522.2
2014
11:20:43
sec
INR
Jul-152.0
2014
11:20:43
Ratio
PT
Jun-1723.1
2014
09:40:00
sec
INR
Jun-172.1
2014
09:40:00
Ratio
CO2
Jun-1728.5
2014
09:40:00
mEq/L
21.0-33.0
NA
Jun-17140
2014
09:40:00
mmol/L
135-146
Jun-174.2
2014
09:40:00
mmol/L
3.5-5.3
CL
Jun-17104
2014
09:40:00
mmol/L
98-110
CA
Jun-179.2
2014
09:40:00
mg/dL
8.6-10.2
GLU
Jun-1791
2014
09:40:00
mg/dL
70-100
BUN
Jun-1712
2014
09:40:00
mg/dL
7-25
CREAT
Jun-170.71
2014
09:40:00
mg/dL
0.50-1.20
Jun-17141
2014
09:40:00
U/L
1-30
WBC
Jun-176.2
2014
09:40:00
x10(3) K/uL
3.8-11.0
RBC
Jun-174.15
2014
09:40:00
x10(6) M/uL
3.40-5.30
HGB
Jun-1713.0
2014
09:40:00
g/dL
10.9-14.7
HCT
Jun-1738.5
2014
09:40:00
33.0-43.0
MCV
Jun-1792.8
2014
09:40:00
fl
80.0-96.0
MCH
Jun-17-
pg
26.0-34.0
Normal Fasting Glucose: 70-100 Impaired Fasting Glucose: 101-125 Diagnostic for Diabetes: >=126
31.3
2014
09:40:00
MCHC
Jun-1733.8
2014
09:40:00
g/dL
31.0-36.0
PLT
Jun-17134
2014
09:40:00
x10(3) K/uL
140-400
LYM%
Jun-1741.0
2014
09:40:00
15.0-50.0
MID%
Jun-179.5
2014
09:40:00
0.1-24.0
GRAN%
Jun-1749.5
2014
09:40:00
40.0-80.0
LYM
Jun-172.5
2014
09:40:00
x10(3) K/uL
1.0-4.2
MID
Jun-170.6
2014
09:40:00
x10(3) K/uL
0.0-1.8
GRAN
Jun-173.1
2014
09:40:00
x10(3) K/uL
1.3-8.8
RDW
Jun-1713.3
2014
09:40:00
11.0-16.0
CHOL
Jun-17144
2014
09:40:00
mg/dL
0-200
TRIG
Jun-1784
2014
09:40:00
mg/dL
0-250
HDL
Jun-1746
2014
09:40:00
mg/dL
>40
LDL
Jun-1781
2014
09:40:00
mg/dL
<130
C/HDL RATIO
Jun-173.1
2014
09:40:00
ratio
Jun-170.35
2014
09:40:00
ulU/mL
0.34-5.60
Jun-1742
2014
09:40:00
U/L
9-60
Jun-1732
2014
09:40:00
U/L
10-35
Jun-17119
2014
09:40:00
U/L
40-115
Jun-170.5
2014
09:40:00
mg/dL
0.2-1.2
Jun-174.0
2014
09:40:00
g/dL
3.6-5.1
PT
May-27- 24.8
2014
11:46:07
sec
INR
May-27- 2.4
2014
11:46:07
Ratio
Panel Description:
COMPREHENSIVE PANEL-CRMC
COMP, Outside Lab
May-23- Comp2014
Outside
13:48:00 Lab. See
Scanned
Report.
May-23- LIPID2014
Outside
13:48:00 Lab. See
Scanned
Report.
May-23- Performed
2014
At CRMC13:48:00 See
Scanned
Report
May-23- Performed
2014
At CRMC13:48:00 See
Scanned
Report
May-14- Performed
2014
At CRMC09:17:16 See
Scanned
Report
Panel Description:
COMPREHENSIVE PANEL-CRMC
COMP, Outside Lab
May-14- Comp2014
Outside
09:17:16 Lab. See
Scanned
Report.
Panel Description: Protime
PT
May-12- 15.2
2014
11:19:22
sec
INR
May-12- 1.5
2014
11:19:22
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
PT
Apr-2818.2
2014
10:43:00
sec
INR
Apr-281.8
2014
10:43:00
Ratio
Apr-1448.8
2014
12:16:27
sec
INR
Apr-144.6
2014
12:16:27
Ratio
HH
PT
Mar-1833.1
2014
11:32:09
sec
INR
Mar-183.1
2014
11:32:09
Ratio
PT
Feb-1724.6
2014
11:16:17
sec
INR
Feb-172.4
2014
11:16:17
Ratio
PT
Feb-0419.6
2014
11:28:42
sec
INR
Feb-041.9
2014
11:28:42
Ratio
PT
Jan-0621.3
2014
10:00:00
sec
INR
Jan-062.0
2014
10:00:00
Ratio
PT
Dec-2319.6
2013
10:52:01
sec
INR
Dec-231.9
2013
10:52:01
Ratio
PT
Dec-1835.9
2013
09:56:04
sec
INR
Dec-183.4
2013
09:56:04
Ratio
Dec-1819
2013
09:56:04
U/L
9-60
Dec-180.57
2013
09:56:04
ulU/mL
0.34-5.60
Dec-18-
mg/dL
0-200
143
2013
09:56:04
TRIG
Dec-18100
2013
09:56:04
mg/dL
0-250
HDL
Dec-1843
2013
09:56:04
mg/dL
>40
LDL
Dec-1880
2013
09:56:04
mg/dL
<130
C/HDL RATIO
Dec-183.3
2013
09:56:04
ratio
CO2
Dec-1828.1
2013
09:56:04
mEq/L
21.0-33.0
NA
Dec-18137
2013
09:56:04
mmol/L
135-146
Dec-183.9
2013
09:56:04
mmol/L
3.5-5.3
CL
Dec-18102
2013
09:56:04
mmol/L
98-110
CA
Dec-189.1
2013
09:56:04
mg/dL
8.6-10.2
GLU
Dec-1892
2013
09:56:04
mg/dL
70-100
BUN
Dec-1812
2013
09:56:04
mg/dL
7-25
CREAT
Dec-180.72
2013
09:56:04
mg/dL
0.50-1.20
WBC
Dec-187.2
2013
09:56:04
x10(3) K/uL
3.8-11.0
RBC
Dec-184.35
2013
09:56:04
x10(6) M/uL
3.40-5.30
HGB
Dec-1813.3
2013
09:56:04
g/dL
10.9-14.7
HCT
Dec-1840.0
2013
09:56:04
33.0-43.0
MCV
Dec-1892.0
2013
09:56:04
fl
80.0-96.0
MCH
Dec-18-
pg
26.0-34.0
30.6
Normal Fasting Glucose: 70-100 Impaired Fasting Glucose: 101-125 Diagnostic for Diabetes: >=126
2013
09:56:04
MCHC
Dec-1833.3
2013
09:56:04
g/dL
31.0-36.0
PLT
Dec-18178
2013
09:56:04
x10(3) K/uL
140-400
LYM%
Dec-1834.4
2013
09:56:04
15.0-50.0
MID%
Dec-186.4
2013
09:56:04
0.1-24.0
GRAN%
Dec-1859.2
2013
09:56:04
40.0-80.0
LYM
Dec-182.5
2013
09:56:04
x10(3) K/uL
1.0-4.2
MID
Dec-180.5
2013
09:56:04
x10(3) K/uL
0.0-1.8
GRAN
Dec-184.2
2013
09:56:04
x10(3) K/uL
1.3-8.8
RDW
Dec-1813.1
2013
09:56:04
11.0-16.0
PT
Nov-19- 27.0
2013
11:19:04
sec
INR
Nov-19- 2.6
2013
11:19:04
Ratio
PT
Oct-2227.5
2013
11:12:00
sec
INR
Oct-222.6
2013
11:12:00
Ratio
PT
Sep-2425.6
2013
10:32:57
sec
INR
Sep-242.4
2013
10:32:57
Ratio
PT
Sep-0329.1
2013
11:24:00
sec
INR
Sep-032.8
2013
11:24:00
Ratio
Aug-06- 26.5
2013
11:20:19
sec
INR
Aug-06- 2.5
2013
11:20:19
Ratio
CHOL
Aug-06- 132
2013
11:20:19
mg/dL
0-200
TRIG
Aug-06- 81
2013
11:20:19
mg/dL
0-250
HDL
Aug-06- 42
2013
11:20:19
mg/dL
>40
LDL
Aug-06- 74
2013
11:20:19
mg/dL
<130
C/HDL RATIO
Aug-06- 3.1
2013
11:20:19
ratio
CO2
Aug-06- 29.4
2013
11:20:19
mEq/L
21.0-33.0
NA
Aug-06- 137
2013
11:20:19
mmol/L
135-146
Aug-06- 4.5
2013
11:20:19
mmol/L
3.5-5.3
CL
Aug-06- 104
2013
11:20:19
mmol/L
98-110
CA
Aug-06- 9.3
2013
11:20:19
mg/dL
8.6-10.2
GLU
Aug-06- 89
2013
11:20:19
mg/dL
70-100
BUN
Aug-06- 14
2013
11:20:19
mg/dL
7-25
CREAT
Aug-06- 0.84
2013
11:20:19
mg/dL
0.50-1.20
WBC
Aug-06- 7.2
2013
11:20:19
x10(3) K/uL
3.8-11.0
RBC
Aug-06- 4.33
2013
11:20:19
x10(6) M/uL
3.40-5.30
HGB
Aug-06-
g/dL
10.9-14.7
13.4
Normal Fasting Glucose: 70-100 Impaired Fasting Glucose: 101-125 Diagnostic for Diabetes: >=126
2013
11:20:19
HCT
Aug-06- 40.0
2013
11:20:19
33.0-43.0
MCV
Aug-06- 92.4
2013
11:20:19
fl
80.0-96.0
MCH
Aug-06- 30.9
2013
11:20:19
pg
26.0-34.0
MCHC
Aug-06- 33.5
2013
11:20:19
g/dL
31.0-36.0
PLT
Aug-06- 140
2013
11:20:19
x10(3) K/uL
140-400
LYM%
Aug-06- 33.1
2013
11:20:19
15.0-50.0
MID%
Aug-06- 10.2
2013
11:20:19
0.1-24.0
GRAN%
Aug-06- 56.7
2013
11:20:19
40.0-80.0
LYM
Aug-06- 2.4
2013
11:20:19
x10(3) K/uL
1.0-4.2
MID
Aug-06- 0.7
2013
11:20:19
x10(3) K/uL
0.0-1.8
GRAN
Aug-06- 4.1
2013
11:20:19
x10(3) K/uL
1.3-8.8
RDW
Aug-06- 12.9
2013
11:20:19
11.0-16.0
Aug-06- 0.29
2013
11:20:19
ulU/mL
0.34-5.60
Aug-06- 17
2013
11:20:19
U/L
9-60
PT
Jul-1125.3
2013
11:50:00
sec
INR
Jul-112.4
2013
11:50:00
Ratio
Jun-1323.0
2013
10:25:00
sec
INR
Jun-132.2
2013
10:25:00
Ratio
PT
May-16- 24.5
2013
11:32:27
sec
INR
May-16- 2.3
2013
11:32:27
Ratio
Panel Description:
COMPREHENSIVE PANEL-CRMC
COMP, Outside Lab
May-09- Comp2013
Outside
12:12:11 Lab. See
Scanned
Report.
Apr-2324.6
2013
11:07:07
sec
INR
Apr-232.3
2013
11:07:07
Ratio
PT
Apr-0225.6
2013
10:55:06
sec
INR
Apr-022.4
2013
10:55:06
Ratio
WBC
Apr-026.8
2013
10:55:06
x10(3) K/uL
3.8-11.0
RBC
Apr-024.31
2013
10:55:06
x10(6) M/uL
3.40-5.30
HGB
Apr-0213.4
2013
10:55:06
g/dL
10.9-14.7
HCT
Apr-0240.2
2013
10:55:06
33.0-43.0
MCV
Apr-0293.3
2013
10:55:06
fl
80.0-96.0
MCH
Apr-0231.1
2013
10:55:06
pg
26.0-34.0
MCHC
Apr-0233.3
2013
10:55:06
g/dL
31.0-36.0
PLT
Apr-02154
2013
10:55:06
x10(3) K/uL
140-400
LYM%
Apr-02-
15.0-50.0
34.1
2013
10:55:06
MID%
Apr-029.7
2013
10:55:06
0.1-24.0
GRAN%
Apr-0256.2
2013
10:55:06
40.0-80.0
LYM
Apr-022.3
2013
10:55:06
x10(3) K/uL
1.0-4.2
MID
Apr-020.7
2013
10:55:06
x10(3) K/uL
0.0-1.8
GRAN
Apr-023.8
2013
10:55:06
x10(3) K/uL
1.3-8.8
RDW
Apr-0213.5
2013
10:55:06
11.0-16.0
Apr-021.37
2013
10:55:06
ulU/mL
0.34-5.60
Apr-02Yellow
2013
10:55:06
APP
Apr-02Clear
2013
10:55:06
GLUC
Apr-02Negative
2013
10:55:06
Negative
BILI
Apr-02Negative
2013
10:55:06
Negative
KET
Apr-02Negative
2013
10:55:06
Negative
SG
Apr-02<=1.005
2013
10:55:06
1.0001.030
pH
Apr-027.0
2013
10:55:06
PROT
Apr-02Negative
2013
10:55:06
NegativeTrace
UROBIL
Apr-020.2
2013
E.U./dL
10:55:06
0.2-1.0
NIT
Apr-02Negative
2013
10:55:06
Negative
BLD
Apr-022013
Negative
Tracelysed
10:55:06
LEUK
Apr-02Negative
2013
10:55:06
Negative
AMORPH
Apr-02None Seen
2013
10:55:06
EPI
Apr-020-3
2013
10:55:06
None Seen
WBCU
Apr-02None Seen
2013
10:55:06
None Seen
RBCU
Apr-02Rare
2013
10:55:06
None Seen
CAST
Apr-02None Seen
2013
10:55:06
None Seen
BACT
Apr-02Trace
2013
10:55:06
None Seen
CRY
Apr-02None Seen
2013
10:55:06
None Seen
MUC
Apr-02None Seen
2013
10:55:06
None Seen
OTHER
Apr-02None Seen
2013
10:55:06
None Seen
/hpf
Mar-1224.6
2013
12:42:40
sec
INR
Mar-122.3
2013
12:42:40
Ratio
PT
Feb-2123.4
2013
10:29:03
sec
INR
Feb-212.2
2013
10:29:03
Ratio
CO2
Feb-2128.9
2013
10:29:03
mEq/L
21.0-33.0
NA
Feb-21138
2013
10:29:03
mmol/L
135-146
Feb-214.3
2013
10:29:03
mmol/L
3.5-5.3
CL
Feb-21-
mmol/L
98-110
102
2013
10:29:03
CA
Feb-219.1
2013
10:29:03
mg/dL
8.6-10.2
GLU
Feb-2187
2013
10:29:03
mg/dL
70-100
BUN
Feb-2117
2013
10:29:03
mg/dL
7-25
CREAT
Feb-210.82
2013
10:29:03
mg/dL
0.50-1.20
CHOL
Feb-21151
2013
10:29:03
mg/dL
0-200
TRIG
Feb-21137
2013
10:29:03
mg/dL
0-250
HDL
Feb-2147
2013
10:29:03
mg/dL
>40
LDL
Feb-2177
2013
10:29:03
mg/dL
<130
C/HDL RATIO
Feb-213.2
2013
10:29:03
ratio
Feb-2126
2013
10:29:03
U/L
9-60
Feb-12Negative
2013
11:16:28
Negative
FLU B
Feb-12Negative
2013
11:16:28
Negative
Feb-0723.8
2013
11:22:39
sec
INR
Feb-072.3
2013
11:22:39
Ratio
PT
Jan-1525.0
2013
15:13:00
sec
INR
Jan-152.4
2013
15:13:00
Ratio
Normal Fasting Glucose: 70-100 Impaired Fasting Glucose: 101-125 Diagnostic for Diabetes: >=126
PT Test Site
Jan-15Performed
2013
at CRMC
15:13:00
Jan-15Performed
2013
at outside
15:08:00 lab-See
Scanned
Report
Oct-16Performed
2012
at outside
10:36:00 lab-See
Scanned
Report
Panel Description:
COMPREHENSIVE PANEL-Outside
Lab
COMP, Outside Lab
Oct-16Comp2012
Outside
10:36:00 Lab. See
Scanned
Report.
Dec-2723.9
2012
12:13:03
sec
INR
Dec-272.3
2012
12:13:03
Ratio
PT
Nov-15- 21.9
2012
13:00:00
sec
INR
Nov-15- 2.1
2012
13:00:00
Ratio
PT
Dec-0622.9
2012
09:55:00
sec
INR
Dec-062.2
2012
09:55:00
Ratio
PT
Oct-2327.3
2012
10:25:47
sec
INR
Oct-232.6
2012
10:25:47
Ratio
Oct-23133
2012
10:25:47
mg/dL
0-200
TRIG
Oct-23109
2012
10:25:47
mg/dL
0-250
HDL
Oct-2337
2012
10:25:47
mg/dL
>40
LDL
Oct-2374
2012
10:25:47
mg/dL
<130
C/HDL RATIO
Oct-233.6
2012
10:25:47
ratio
Oct-231.24
2012
10:25:47
ulU/mL
0.34-5.60
Oct-16Performed
2012
At CRMC13:36:40 See
Scanned
Report
Panel Description:
COMPREHENSIVE PANEL-CRMC
COMP, Outside Lab
Oct-16Comp2012
Outside
13:36:40 Lab. See
Scanned
Report.
Oct-0223.5
2012
11:23:21
sec
INR
Oct-022.2
2012
11:23:21
Ratio
PT
Sep-1129.4
2012
12:02:05
sec
INR
Sep-112.8
2012
12:02:05
Ratio
WBC
Aug-28- 7.8
2012
11:20:00
x10(3) K/uL
3.8-11.0
RBC
Aug-28- 4.39
2012
11:20:00
x10(6) M/uL
3.40-5.30
HGB
Aug-28- 13.9
2012
11:20:00
g/dL
10.9-14.7
HCT
Aug-28- 40.3
2012
11:20:00
33.0-43.0
MCV
Aug-28-
fl
80.0-96.0
91.8
2012
11:20:00
MCH
Aug-28- 31.7
2012
11:20:00
pg
26.0-34.0
MCHC
Aug-28- 34.5
2012
11:20:00
g/dL
31.0-36.0
PLT
Aug-28- 118
2012
11:20:00
x10(3) K/uL
140-400
LYM%
Aug-28- 32.5
2012
11:20:00
15.0-50.0
MID%
Aug-28- 8.8
2012
11:20:00
0.1-24.0
GRAN%
Aug-28- 58.7
2012
11:20:00
40.0-80.0
LYM
Aug-28- 2.5
2012
11:20:00
x10(3) K/uL
1.0-4.2
MID
Aug-28- 0.7
2012
11:20:00
x10(3) K/uL
0.0-1.8
GRAN
Aug-28- 4.6
2012
11:20:00
x10(3) K/uL
1.3-8.8
RDW
Aug-28- 12.5
2012
11:20:00
11.0-16.0
PT
Aug-28- 15.3
2012
11:20:00
sec
INR
Aug-28- 1.4
2012
11:20:00
Ratio
PT
Aug-14- 16.4
2012
12:35:00
sec
INR
Aug-14- 1.6
2012
12:35:00
Ratio
WBC
Aug-14- 6.5
2012
12:35:00
x10(3) K/uL
3.8-11.0
RBC
Aug-14- 4.32
2012
12:35:00
x10(6) M/uL
3.40-5.30
HGB
Aug-14- 13.3
2012
12:35:00
g/dL
10.9-14.7
HCT
Aug-14-
33.0-43.0
39.7
2012
12:35:00
MCV
Aug-14- 91.9
2012
12:35:00
fl
80.0-96.0
MCH
Aug-14- 30.8
2012
12:35:00
pg
26.0-34.0
MCHC
Aug-14- 33.5
2012
12:35:00
g/dL
31.0-36.0
PLT
Aug-14- 116
2012
12:35:00
x10(3) K/uL
140-400
LYM%
Aug-14- 34.8
2012
12:35:00
15.0-50.0
MID%
Aug-14- 7.7
2012
12:35:00
0.1-24.0
GRAN%
Aug-14- 57.5
2012
12:35:00
40.0-80.0
LYM
Aug-14- 2.3
2012
12:35:00
x10(3) K/uL
1.0-4.2
MID
Aug-14- 0.5
2012
12:35:00
x10(3) K/uL
0.0-1.8
GRAN
Aug-14- 3.7
2012
12:35:00
x10(3) K/uL
1.3-8.8
RDW
Aug-14- 12.5
2012
12:35:00
11.0-16.0
CARDIOLIPIN AB (IGA)
Aug-14- <11
2012
12:35:00
APL
CARDIOLIPIN AB (IGG)
Aug-14- <14
2012
12:35:00
GPL
CARDIOLIPIN AB (IGM)
Aug-14- <12
2012
12:35:00
MPL
The antiphospholipid antibody syndrome (APS) is a clinical-pathologic correlation that includes a clinical
event(e.g. thrombosis, pregnancy loss, thrombocytopenia) and persistent positive antiphospholipid
antibodies (IgM or IgG ACA >40 MPL/GPL, IgM or IgG anti-b2GPI antibodies or a lupus anticoagulant). The
IgA isotype has been implicated in smaller studies, but have not yet been incorporated into the APS
criteria. International consensus guidelines suggest waiting at least 12 weeks before retesting to confirm
antibody persistence. Reference J Thromb Haemost 2006: 4; 295
Jul-2320.7
2012
14:22:47
sec
INR
Jul-23-
Ratio
2.0
2012
14:22:47
PT Test Site
Jul-23Performed
2012
at CRMC
14:22:47
Jul-1815.6
2012
11:11:47
sec
INR
Jul-181.8
2012
11:11:47
Ratio
Jul-18NEGATIVE
2012
11:11:47
IGM
Jul-18NEGATIVE
2012
11:11:47
IGA
Jul-18NEGATIVE
2012
11:11:47
REFERENCE RANGE: NEGATIVE INTERPRETIVE CRITERIA: NEGATIVE: Antibody Not Detected EQUIVOCAL:
Borderline result; submission of second specimen recommended POSITIVE: Antibody Detected Elevated
levels of platelet-associated antibodies may occur in autoimmune thrombocytopenia, as well as
thrombocytopenia associated with carcinoma, AIDS, and connective tissue diseases. Platelet- associated
antibodies may consist of a single isotype (IgG, IgM, or IgA) or any combination of isotypes. This assay
was developed and its performance characteristics have been determined by Focus Diagnostics. It has not
been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such
clearance or approval is not necessary. Performance characteristics refer to the analytical performance of
the test.
Panel Description:
LEVETIRACETAM(Keppra)
LEVETIRACETAM
Jul-1821.8
2012
11:11:47
mcg/mL
*** Unable to flag abnormal result(s), please refer to reference range(s) below: Therapeutic Levels: Drug
Dosage Trough Peak 500 mg BID 3.1-10.0 mcg/mL 10.0-25.0 mcg/mL 1000 mg BID 4.9-37.1 mcg/mL
30.0-40.0 mcg/mL 1500 mg BID 7.0-34.0 mcg/mL 36.1-70.0 mcg/mL Toxic level: Not established
PT
Jun-2816.1
2012
10:40:00
sec
INR
Jun-281.9
2012
10:40:00
Ratio
CHOL
Jun-28145
2012
10:40:00
mg/dL
0-200
TRIG
Jun-2891
2012
10:40:00
mg/dL
0-250
HDL
Jun-2842
2012
10:40:00
mg/dL
>40
LDL
Jun-2885
2012
10:40:00
mg/dL
<130
C/HDL RATIO
Jun-283.5
2012
10:40:00
ratio
Jun-2829.1
2012
10:40:00
mEq/L
21.0-33.0
NA
Jun-28136
2012
10:40:00
mmol/L
135-146
Jun-284.1
2012
10:40:00
mmol/L
3.5-5.3
CL
Jun-28101
2012
10:40:00
mmol/L
98-110
CA
Jun-289.5
2012
10:40:00
mg/dL
8.6-10.2
GLU
Jun-2888
2012
10:40:00
mg/dL
70-100
BUN
Jun-2817
2012
10:40:00
mg/dL
7-25
CREAT
Jun-280.84
2012
10:40:00
mg/dL
0.50-1.20
WBC
Jun-286.4
2012
10:40:00
x10(3) K/uL
3.8-11.0
RBC
Jun-284.40
2012
10:40:00
x10(6) M/uL
3.40-5.30
HGB
Jun-2813.7
2012
10:40:00
g/dL
10.9-14.7
HCT
Jun-2840.7
2012
10:40:00
33.0-43.0
MCV
Jun-2892.5
2012
10:40:00
fl
80.0-96.0
MCH
Jun-2831.1
2012
10:40:00
pg
26.0-34.0
MCHC
Jun-2833.7
2012
10:40:00
g/dL
31.0-36.0
PLT
Jun-28102
2012
10:40:00
x10(3) K/uL
140-400
LYM%
Jun-2836.7
2012
10:40:00
15.0-50.0
MID%
Jun-289.5
2012
10:40:00
0.1-24.0
Normal Fasting Glucose: 70-100 Impaired Fasting Glucose: 101-125 Diagnostic for Diabetes: >=126
GRAN%
Jun-2853.8
2012
10:40:00
40.0-80.0
LYM
Jun-282.3
2012
10:40:00
x10(3) K/uL
1.0-4.2
MID
Jun-280.6
2012
10:40:00
x10(3) K/uL
0.0-1.8
GRAN
Jun-283.5
2012
10:40:00
x10(3) K/uL
1.3-8.8
RDW
Jun-2813.2
2012
10:40:00
11.0-16.0
Jun-280.68
2012
10:40:00
ulU/mL
0.34-5.60
Jun-2817
2012
10:40:00
U/L
9-60
Jun-28NEGATIVE
2012
10:40:00
NEGATIVE
Jun-1318.3
2012
11:59:32
sec
INR
Jun-132.4
2012
11:59:32
Ratio
PT
May-23- 16.5
2012
09:51:14
sec
INR
May-23- 2.0
2012
09:51:14
Ratio
WBC
May-23- 5.9
2012
09:51:14
x10(3) K/uL
3.8-11.0
RBC
May-23- 4.19
2012
09:51:14
x10(6) M/uL
3.40-5.30
HGB
May-23- 13.2
2012
09:51:14
g/dL
10.9-14.7
HCT
May-23- 39.2
2012
09:51:14
33.0-43.0
MCV
May-23-
fl
80.0-96.0
93.6
2012
09:51:14
MCH
May-23- 31.5
2012
09:51:14
pg
26.0-34.0
MCHC
May-23- 33.7
2012
09:51:14
g/dL
31.0-36.0
PLT
May-23- 119
2012
09:51:14
x10(3) K/uL
140-400
LYM%
May-23- 32.7
2012
09:51:14
15.0-50.0
MID%
May-23- 9.1
2012
09:51:14
0.1-24.0
GRAN%
May-23- 58.2
2012
09:51:14
40.0-80.0
LYM
May-23- 1.9
2012
09:51:14
x10(3) K/uL
1.0-4.2
MID
May-23- 0.5
2012
09:51:14
x10(3) K/uL
0.0-1.8
GRAN
May-23- 3.5
2012
09:51:14
x10(3) K/uL
1.3-8.8
RDW
May-23- 13.2
2012
09:51:14
11.0-16.0
PT
May-02- 18.1
2012
12:25:00
sec
INR
May-02- 2.4
2012
12:25:00
Ratio
PT
Apr-1619.9
2012
10:25:18
sec
INR
Apr-162.8
2012
10:25:18
Ratio
WBC
Apr-136.9
2012
10:24:08
x10(3) K/uL
3.8-11.0
RBC
Apr-134.23
2012
10:24:08
x10(6) M/uL
3.40-5.30
HGB
Apr-1313.1
2012
10:24:08
g/dL
10.9-14.7
HCT
Apr-13-
33.0-43.0
39.8
2012
10:24:08
MCV
Apr-1394.1
2012
10:24:08
fl
80.0-96.0
MCH
Apr-1331.0
2012
10:24:08
pg
26.0-34.0
MCHC
Apr-1332.9
2012
10:24:08
g/dL
31.0-36.0
PLT
Apr-13131
2012
10:24:08
x10(3) K/uL
140-400
LYM%
Apr-1333.3
2012
10:24:08
15.0-50.0
MID%
Apr-1310.2
2012
10:24:08
0.1-24.0
GRAN%
Apr-1356.5
2012
10:24:08
40.0-80.0
LYM
Apr-132.3
2012
10:24:08
x10(3) K/uL
1.0-4.2
MID
Apr-130.7
2012
10:24:08
x10(3) K/uL
0.0-1.8
GRAN
Apr-133.9
2012
10:24:08
x10(3) K/uL
1.3-8.8
RDW
Apr-1313.2
2012
10:24:08
11.0-16.0
PT
Apr-1312.4
2012
10:24:08
sec
INR
Apr-131.2
2012
10:24:08
Ratio
CO2
Mar-2328.1
2012
11:47:00
mEq/L
21.0-33.0
NA
Mar-23138
2012
11:47:00
mmol/L
135-146
Mar-234.3
2012
11:47:00
mmol/L
3.5-5.3
CL
Mar-23102
2012
11:47:00
mmol/L
98-110
CA
Mar-23-
mg/dL
8.6-10.2
9.0
2012
11:47:00
GLU
Mar-2380
2012
11:47:00
mg/dL
70-100
BUN
Mar-2314
2012
11:47:00
mg/dL
7-25
CREAT
Mar-230.92
2012
11:47:00
mg/dL
0.50-1.20
WBC
Mar-236.7
2012
11:47:00
x10(3) K/uL
3.8-11.0
RBC
Mar-234.37
2012
11:47:00
x10(6) M/uL
3.40-5.30
HGB
Mar-2313.4
2012
11:47:00
g/dL
10.9-14.7
HCT
Mar-2341.3
2012
11:47:00
33.0-43.0
MCV
Mar-2394.5
2012
11:47:00
fl
80.0-96.0
MCH
Mar-2330.7
2012
11:47:00
pg
26.0-34.0
MCHC
Mar-2332.4
2012
11:47:00
g/dL
31.0-36.0
PLT
Mar-23132
2012
11:47:00
x10(3) K/uL
140-400
LYM%
Mar-2330.1
2012
11:47:00
15.0-50.0
MID%
Mar-238.5
2012
11:47:00
0.1-24.0
GRAN%
Mar-2361.4
2012
11:47:00
40.0-80.0
LYM
Mar-232.0
2012
11:47:00
x10(3) K/uL
1.0-4.2
MID
Mar-230.6
2012
11:47:00
x10(3) K/uL
0.0-1.8
GRAN
Mar-234.1
2012
11:47:00
x10(3) K/uL
1.3-8.8
RDW
Mar-2313.8
2012
11:47:00
11.0-16.0
Normal Fasting Glucose: 70-100 Impaired Fasting Glucse: 101-125 Diagnostic for Diabetes: >=126
Mar-233.1
2012
11:47:00
mg/dL
2.1-4.3
PT
Mar-2320.9
2012
11:47:00
sec
INR
Mar-233.0
2012
11:47:00
Ratio
Mar-2333
2012
11:47:00
sec
PT
Mar-0220.6
2012
10:16:44
sec
INR
Mar-022.9
2012
10:16:44
Ratio
CO2
Mar-0227.9
2012
10:16:44
mEq/L
21.0-33.0
NA
Mar-02136
2012
10:16:44
mmol/L
135-146
Mar-024.1
2012
10:16:44
mmol/L
3.5-5.3
CL
Mar-02100
2012
10:16:44
mmol/L
98-110
CA
Mar-029.2
2012
10:16:44
mg/dL
8.6-10.2
GLU
Mar-0288
2012
10:16:44
mg/dL
70-100
BUN
Mar-0214
2012
10:16:44
mg/dL
7-25
CREAT
Mar-020.84
2012
10:16:44
mg/dL
0.50-1.20
WBC
Mar-028.2
2012
10:16:44
x10(3) K/uL
3.8-11.0
RBC
Mar-024.23
2012
10:16:44
x10(6) M/uL
3.40-5.30
22-34
The therapeutic range for unfractionated heparin therapy is 1.5-2.5 times the mean of the reference
interval. In patients in whom there is an apparent heparin resistance, a heparin level by an anti-Xa method
is available.
Normal Fasting Glucose: 70-100 Impaired Fasting Glucse: 101-125 Diagnostic for Diabetes: >=126
HGB
Mar-0213.1
2012
10:16:44
g/dL
10.9-14.7
HCT
Mar-0239.8
2012
10:16:44
33.0-43.0
MCV
Mar-0294.1
2012
10:16:44
fl
80.0-96.0
MCH
Mar-0231.0
2012
10:16:44
pg
26.0-34.0
MCHC
Mar-0232.9
2012
10:16:44
g/dL
31.0-36.0
PLT
Mar-02140
2012
10:16:44
x10(3) K/uL
140-400
LYM%
Mar-0228.3
2012
10:16:44
15.0-50.0
MID%
Mar-028.5
2012
10:16:44
0.1-24.0
GRAN%
Mar-0263.2
2012
10:16:44
40.0-80.0
LYM
Mar-022.3
2012
10:16:44
x10(3) K/uL
1.0-4.2
MID
Mar-020.7
2012
10:16:44
x10(3) K/uL
0.0-1.8
GRAN
Mar-025.2
2012
10:16:44
x10(3) K/uL
1.3-8.8
RDW
Mar-0214.4
2012
10:16:44
11.0-16.0
CHOL
Mar-02150
2012
10:16:44
mg/dL
0-200
TRIG
Mar-0278
2012
10:16:44
mg/dL
0-250
HDL
Mar-0253
2012
10:16:44
mg/dL
>40
LDL
Mar-0281
2012
10:16:44
mg/dL
<130
C/HDL RATIO
Mar-022.8
2012
10:16:44
ratio
Mar-02-
U/L
16
9-60
2012
10:16:44
Panel Description: Protime
PT
Feb-1020.1
2012
10:28:15
sec
INR
Feb-102.8
2012
10:28:15
Ratio
PT
Jan-1918.1
2012
11:40:00
sec
INR
Jan-192.4
2012
11:40:00
Ratio
Jan-194.90
2012
11:40:00
ulU/mL
0.34-5.60
Jan-191.61
2012
11:40:00
ng/dL
0.54-1.60
PT
Jan-1212.4
2012
13:20:00
sec
INR
Jan-121.2
2012
13:20:00
Ratio
CO2
Jan-1230.7
2012
13:20:00
mEq/L
21.0-33.0
NA
Jan-12136
2012
13:20:00
mmol/L
135-146
Jan-124.6
2012
13:20:00
mmol/L
3.5-5.3
CL
Jan-1298
2012
13:20:00
mmol/L
98-110
CA
Jan-129.4
2012
13:20:00
mg/dL
8.6-10.2
GLU
Jan-1286
2012
13:20:00
mg/dL
70-100
BUN
Jan-1216
2012
13:20:00
mg/dL
7-25
CREAT
Jan-122012
mg/dL
0.50-1.20
0.98
Normal Fasting Glucose: 70-100 Impaired Fasting Glucse: 101-125 Diagnostic for Diabetes: >=126
13:20:00
Panel Description: CBC
WBC
Jan-127.9
2012
13:20:00
x10(3) K/uL
3.8-11.0
RBC
Jan-124.12
2012
13:20:00
x10(6) M/uL
3.40-5.30
HGB
Jan-1212.6
2012
13:20:00
g/dL
10.9-14.7
HCT
Jan-1239.2
2012
13:20:00
33.0-43.0
MCV
Jan-1295.1
2012
13:20:00
fl
80.0-96.0
MCH
Jan-1230.6
2012
13:20:00
pg
26.0-34.0
MCHC
Jan-1232.1
2012
13:20:00
g/dL
31.0-36.0
PLT
Jan-12140
2012
13:20:00
x10(3) K/uL
140-400
LYM%
Jan-1231.4
2012
13:20:00
15.0-50.0
MID%
Jan-1212.9
2012
13:20:00
0.1-24.0
GRAN%
Jan-1255.7
2012
13:20:00
40.0-80.0
LYM
Jan-122.5
2012
13:20:00
x10(3) K/uL
1.0-4.2
MID
Jan-121.0
2012
13:20:00
x10(3) K/uL
0.0-1.8
GRAN
Jan-124.4
2012
13:20:00
x10(3) K/uL
1.3-8.8
RDW
Jan-1215.0
2012
13:20:00
11.0-16.0
Jan-122.2
2012
13:20:00
mg/dL
1.5-2.5
PT
Jan-0313.1
2012
11:43:04
sec
INR
Jan-032012
Ratio
1.3
11:43:04
Panel Description: Protime
PT
Dec-2716.9
2011
14:30:00
sec
INR
Dec-272.1
2011
14:30:00
Ratio
WBC
Dec-2715.8
2011
14:30:00
x10(3) K/uL
3.8-11.0
RBC
Dec-274.19
2011
14:30:00
x10(6) M/uL
3.40-5.30
HGB
Dec-2712.7
2011
14:30:00
g/dL
10.9-14.7
HCT
Dec-2739.1
2011
14:30:00
33.0-43.0
MCV
Dec-2793.3
2011
14:30:00
fl
80.0-96.0
MCH
Dec-2730.3
2011
14:30:00
pg
26.0-34.0
MCHC
Dec-2732.5
2011
14:30:00
g/dL
31.0-36.0
PLT
Dec-27217
2011
14:30:00
x10(3) K/uL
140-400
LYM%
Dec-2717.9
2011
14:30:00
15.0-50.0
MID%
Dec-278.3
2011
14:30:00
0.1-24.0
GRAN%
Dec-2773.8
2011
14:30:00
40.0-80.0
LYM
Dec-272.8
2011
14:30:00
x10(3) K/uL
1.0-4.2
MID
Dec-271.3
2011
14:30:00
x10(3) K/uL
0.0-1.8
GRAN
Dec-2711.7
2011
14:30:00
x10(3) K/uL
1.3-8.8
RDW
Dec-2714.2
2011
14:30:00
11.0-16.0
Dec-27-
mEq/L
21.0-33.0
28.2
2011
14:30:00
NA
Dec-27132
2011
14:30:00
mmol/L
135-146
Dec-274.1
2011
14:30:00
mmol/L
3.5-5.3
CL
Dec-2797
2011
14:30:00
mmol/L
98-110
CA
Dec-278.9
2011
14:30:00
mg/dL
8.6-10.2
GLU
Dec-27112
2011
14:30:00
mg/dL
70-100
BUN
Dec-2712
2011
14:30:00
mg/dL
7-25
CREAT
Dec-270.91
2011
14:30:00
mg/dL
0.50-1.20
PT
Nov-23- 16.6
2011
11:08:16
sec
INR
Nov-23- 2.0
2011
11:08:16
Ratio
CO2
Nov-23- 27.3
2011
11:08:16
mEq/L
21.0-33.0
NA
Nov-23- 138
2011
11:08:16
mmol/L
135-146
Nov-23- 4.3
2011
11:08:16
mmol/L
3.5-5.3
CL
Nov-23- 103
2011
11:08:16
mmol/L
98-110
CA
Nov-23- 9.5
2011
11:08:16
mg/dL
8.6-10.2
GLU
Nov-23- 73
2011
11:08:16
mg/dL
70-100
BUN
Nov-23- 15
2011
11:08:16
mg/dL
7-25
CREAT
Nov-23- 0.91
2011
11:08:16
mg/dL
0.50-1.20
Normal Fasting Glucose: 70-100 Impaired Fasting Glucse: 101-125 Diagnostic for Diabetes: >=126
Normal Fasting Glucose: 70-100 Impaired Fasting Glucse: 101-125 Diagnostic for Diabetes: >=126
PT
Nov-02- 16.2
2011
12:04:17
sec
INR
Nov-02- 2.0
2011
12:04:17
Ratio
PT
Oct-1118.3
2011
12:09:19
sec
INR
Oct-112.5
2011
12:09:19
Ratio
PT
Sep-2118.7
2011
10:54:45
sec
INR
Sep-212.6
2011
10:54:45
Ratio
PT
Aug-31- 17.5
2011
11:37:05
sec
INR
Aug-31- 2.3
2011
11:37:05
Ratio
WBC
Aug-31- 9.2
2011
11:37:05
x10(3) K/uL
3.8-11.0
RBC
Aug-31- 4.35
2011
11:37:05
x10(6) M/uL
3.40-5.30
HGB
Aug-31- 13.4
2011
11:37:05
g/dL
10.9-14.7
HCT
Aug-31- 40.1
2011
11:37:05
33.0-43.0
MCV
Aug-31- 92.2
2011
11:37:05
fl
80.0-96.0
MCH
Aug-31- 30.8
2011
11:37:05
pg
26.0-34.0
MCHC
Aug-31- 33.4
2011
11:37:05
g/dL
31.0-36.0
PLT
Aug-31- 201
2011
11:37:05
x10(3) K/uL
140-400
LYM%
Aug-31- 41.4
2011
11:37:05
15.0-50.0
MID%
Aug-312011
0.1-24.0
9.1
11:37:05
GRAN%
Aug-31- 49.5
2011
11:37:05
40.0-80.0
LYM
Aug-31- 3.8
2011
11:37:05
x10(3) K/uL
1.0-4.2
MID
Aug-31- 0.8
2011
11:37:05
x10(3) K/uL
0.0-1.8
GRAN
Aug-31- 4.6
2011
11:37:05
x10(3) K/uL
1.3-8.8
RDW
Aug-31- 12.9
2011
11:37:05
11.0-16.0
Aug-31- 43
2011
11:37:05
mm/hr
0-20
PT
Aug-10- 16.5
2011
10:18:01
sec
INR
Aug-10- 2.1
2011
10:18:01
Ratio
CHOL
Aug-10- 141
2011
10:18:01
mg/dL
0-200
TRIG
Aug-10- 103
2011
10:18:01
mg/dL
0-250
HDL
Aug-10- 45
2011
10:18:01
mg/dL
>40
LDL
Aug-10- 75
2011
10:18:01
mg/dL
<130
C/HDL RATIO
Aug-10- 3.1
2011
10:18:01
ratio
CO2
Aug-10- 28.3
2011
10:18:01
mEq/L
21.0-33.0
NA
Aug-10- 138
2011
10:18:01
mmol/L
135-146
Aug-10- 4.4
2011
10:18:01
mmol/L
3.5-5.3
CL
Aug-102011
mmol/L
98-110
Panel Description:
Sedimentation Rate
SR
102
10:18:01
CA
Aug-10- 9.4
2011
10:18:01
mg/dL
8.6-10.2
GLU
Aug-10- 86
2011
10:18:01
mg/dL
70-100
BUN
Aug-10- 12
2011
10:18:01
mg/dL
7-25
CREAT
Aug-10- 0.87
2011
10:18:01
mg/dL
0.50-1.20
Aug-10- 0.44
2011
10:18:01
ulU/mL
0.34-5.60
Aug-10- 24
2011
10:18:01
U/L
10-35
PT
Jul-2019.8
2011
12:15:00
sec
INR
Jul-202.8
2011
12:15:00
Ratio
PT
Jul-0119.7
2011
10:59:42
sec
INR
Jul-012.8
2011
10:59:42
Ratio
PT
Jun-1018.1
2011
11:21:19
sec
INR
Jun-102.5
2011
11:21:19
Ratio
PT
May-25- 18.0
2011
11:27:18
sec
INR
May-25- 2.4
2011
11:27:18
Ratio
PT
May-04- 16.2
2011
10:34:39
sec
INR
May-042011
Ratio
2.0
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
10:34:39
Panel Description: Protime
PT
Apr-1317.0
2011
11:32:34
sec
INR
Apr-132.2
2011
11:32:34
Ratio
PT
Mar-2319.0
2011
10:11:40
sec
INR
Mar-232.7
2011
10:11:40
Ratio
Mar-2317.1
2011
10:11:40
mcg/mL
PT
Mar-0216.1
2011
10:30:00
sec
INR
Mar-022.0
2011
10:30:00
Ratio
Mar-0239.42
2011
10:30:00
ng/mL
Panel Description:
LEVETIRACETAM(Keppra)
LEVETIRACETAM (KEPPRA)

 *** Unable to flag abnormal result(s), please
 refer to reference range(s) below:

 Therapeutic Levels:
 
 Drug Dosage Trough Peak
 
 500 mg BID 3.110.0 mcg/mL 10.0-25.0 mcg/mL
 1000 mg BID 4.9-37.1 mcg/mL 30.0-40.0 mcg/mL
 1500
mg BID 7.0-34.0 mcg/mL 36.1-70.0 mcg/mL
 
 
 Toxic level: Not established
11.00306.80
Mar-02Yellow
2011
10:30:00
APP
Mar-02Clear
2011
10:30:00
GLUC
Mar-02Negative
2011
10:30:00
Negative
BILI
Mar-02Negative
2011
10:30:00
Negative
KET
Mar-02Negative
2011
10:30:00
Negative
SG
Mar-021.010
2011
10:30:00
1.0001.030
pH
Mar-027.0
2011
10:30:00
PROT
Mar-022011
Negative
NegativeTrace
10:30:00
UROBIL
Mar-020.2
2011
E.U./dL
10:30:00
0.2-1.0
NIT
Mar-02Negative
2011
10:30:00
Negative
BLD
Mar-02Trace2011
lysed
10:30:00
Negative
LEUK
Mar-02Negative
2011
10:30:00
Negative
AMORPH
Mar-02None Seen
2011
10:30:00
EPI
Mar-020-3
2011
10:30:00
None Seen
WBCU
Mar-02None Seen
2011
10:30:00
None Seen
RBCU
Mar-023-5
2011
10:30:00
None Seen
CAST
Mar-02None Seen
2011
10:30:00
None Seen
BACT
Mar-02None Seen
2011
10:30:00
None Seen
CRY
Mar-02None Seen
2011
10:30:00
None Seen
MUC
Mar-02None Seen
2011
10:30:00
None Seen
OTHER
Mar-02None Seen
2011
10:30:00
None Seen
/hpf
Feb-0917.6
2011
10:28:46
sec
INR
Feb-092.3
2011
10:28:46
Ratio
Feb-0921
2011
10:28:46
U/L
9-60
CO2
Feb-0924.5
2011
10:28:46
mEq/L
21.0-33.0
NA
Feb-09-
mmol/L
135-146
139
2011
10:28:46
K
Feb-094.1
2011
10:28:46
mmol/L
3.5-5.3
CL
Feb-09105
2011
10:28:46
mmol/L
98-110
CA
Feb-099.3
2011
10:28:46
mg/dL
8.6-10.2
GLU
Feb-0995
2011
10:28:46
mg/dL
70-100
BUN
Feb-0912
2011
10:28:46
mg/dL
7-25
CREAT
Feb-090.81
2011
10:28:46
mg/dL
0.50-1.20
CHOL
Feb-09141
2011
10:28:46
mg/dL
0-200
TRIG
Feb-0973
2011
10:28:46
mg/dL
0-250
HDL
Feb-0947
2011
10:28:46
mg/dL
>40
LDL
Feb-0979
2011
10:28:46
mg/dL
<130
C/HDL RATIO
Feb-093.0
2011
10:28:46
ratio
Feb-090.99
2011
10:28:46
ulU/mL
PT
Jan-2016.6
2011
11:17:00
sec
INR
Jan-202.1
2011
11:17:00
Ratio
PT
Dec-2918.8
2010
11:22:49
sec
INR
Dec-292.6
2010
11:22:49
Ratio
Dec-08-
sec
17.9
0.34-5.60
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
2010
11:58:21
INR
Dec-082.4
2010
11:58:21
Ratio
PT
Dec-0817.9
2010
11:58:21
sec
INR
Dec-082.4
2010
11:58:21
Ratio
PT
Nov-17- 18.4
2010
12:15:00
sec
INR
Nov-17- 2.5
2010
12:15:00
Ratio
PT
Oct-2719.8
2010
11:42:34
sec
INR
Oct-272.6
2010
11:42:34
Ratio
PT
Oct-0621.2
2010
09:38:41
sec
INR
Oct-062.9
2010
09:38:41
Ratio
PT
Sep-1520.0
2010
08:11:56
sec
INR
Sep-152.6
2010
08:11:56
Ratio
PT
Aug-24- 20.0
2010
09:50:48
sec
INR
Aug-24- 2.6
2010
09:50:48
Ratio
Aug-24- 21
2010
09:50:48
U/L
9-60
Aug-24- 0.36
2010
09:50:48
ulU/mL
0.34-5.60
Aug-24- 24
2010
09:50:48
U/L
10-35
Aug-24- 68
2010
09:50:48
U/L
40-115
Aug-24- 0.5
2010
09:50:48
mg/dL
0.2-1.2
Aug-24- 4.3
2010
09:50:48
g/dL
3.6-5.1
CO2
Aug-24- 27.4
2010
09:50:48
mEq/L
21.0-33.0
NA
Aug-24- 137
2010
09:50:48
mmol/L
135-146
Aug-24- 4.2
2010
09:50:48
mmol/L
3.5-5.3
CL
Aug-24- 104
2010
09:50:48
mmol/L
98-110
CA
Aug-24- 9.1
2010
09:50:48
mg/dL
8.6-10.2
GLU
Aug-24- 87
2010
09:50:48
mg/dL
70-100
BUN
Aug-24- 11
2010
09:50:48
mg/dL
7-25
CREAT
Aug-24- 0.85
2010
09:50:48
mg/dL
0.50-1.20
WBC
Aug-24- 6.3
2010
09:50:48
x10(3) K/uL
3.8-11.0
RBC
Aug-24- 4.46
2010
09:50:48
x10(6) M/uL
3.40-5.30
HGB
Aug-24- 13.8
2010
09:50:48
g/dL
10.9-14.7
HCT
Aug-24- 41.2
2010
09:50:48
33.0-43.0
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
MCV
Aug-24- 92.4
2010
09:50:48
fl
80.0-96.0
MCH
Aug-24- 30.9
2010
09:50:48
pg
26.0-34.0
MCHC
Aug-24- 33.5
2010
09:50:48
g/dL
31.0-36.0
PLT
Aug-24- 220
2010
09:50:48
x10(3) K/uL
140-400
LYM%
Aug-24- 39.3
2010
09:50:48
15.0-50.0
MID%
Aug-24- 8.9
2010
09:50:48
0.1-24.0
GRAN%
Aug-24- 51.8
2010
09:50:48
40.0-80.0
LYM
Aug-24- 2.5
2010
09:50:48
x10(3) K/uL
1.0-4.2
MID
Aug-24- 0.6
2010
09:50:48
x10(3) K/uL
0.0-1.8
GRAN
Aug-24- 3.2
2010
09:50:48
x10(3) K/uL
1.3-8.8
RDW
Aug-24- 12.5
2010
09:50:48
11.0-16.0
CHOL
Aug-24- 145
2010
09:50:48
mg/dL
0-200
TRIG
Aug-24- 136
2010
09:50:48
mg/dL
0-250
HDL
Aug-24- 43
2010
09:50:48
mg/dL
>40
LDL
Aug-24- 75
2010
09:50:48
mg/dL
<130
C/HDL RATIO
Aug-24- 3.4
2010
09:50:48
ratio
Aug-24- 35
2010
09:50:48
mm/hr
Aug-032010
sec
Panel Description:
Sedimentation Rate
SR
21.5
0-20
10:43:04
INR
Aug-03- 3.0
2010
10:43:04
Ratio
PT
Jul-1319.6
2010
11:32:37
sec
INR
Jul-132.6
2010
11:32:37
Ratio
PT
Jun-2220.9
2010
11:19:00
sec
INR
Jun-222.8
2010
11:19:00
Ratio
PT
Jun-0121.5
2010
10:50:00
sec
INR
Jun-013.0
2010
10:50:00
Ratio
Jun-010.23
2010
10:50:00
IU/mL
PT
May-24- 22.7
2010
12:05:21
sec
INR
May-24- 3.3
2010
12:05:21
Ratio
PT
May-12- 20.7
2010
11:50:00
sec
INR
May-12- 2.8
2010
11:50:00
Ratio
Apr-21-
sec
20.2
>0.15
2010
11:05:00
INR
Apr-212.7
2010
11:05:00
Ratio
PT
Apr-0724.3
2010
11:20:00
sec
INR
Apr-073.7
2010
11:20:00
Ratio
PT
Mar-1719.0
2010
09:00:00
sec
INR
Mar-172.4
2010
09:00:00
Ratio
CHOL
Mar-17125
2010
09:00:00
mg/dL
0-200
TRIG
Mar-1770
2010
09:00:00
mg/dL
0-250
HDL
Mar-1751
2010
09:00:00
mg/dL
>40
LDL
Mar-1760
2010
09:00:00
mg/dL
<130
C/HDL RATIO
Mar-172.5
2010
09:00:00
ratio
Mar-171.38
2010
09:00:00
ulU/mL
0.34-5.60
PROTEIN, TOTAL
Mar-177.9
2010
09:00:00
g/dL
6.2-8.3
ALBUMIN
Mar-174.0
2010
09:00:00
g/dL
3.5-4.7
ALPHA-1-GLOBULINS
Mar-170.3
2010
09:00:00
g/dL
0.1-0.3
ALPHA-2-GLOBULINS
Mar-171.0
2010
09:00:00
g/dL
0.5-1.0
BETA GLOBULINS
Mar-171.3
2010
09:00:00
g/dL
0.8-1.4
HH
GAMMA GLOBULINS
Mar-171.3
2010
09:00:00
INTERPRETATION
Mar-17SEE NOTE
2010
09:00:00
g/dL
0.6-1.6
NORMAL PATTERN
Mar-1725.4
2010
09:00:00
mEq/L
21.0-33.0
NA
Mar-17137
2010
09:00:00
mmol/L
135-146
Mar-173.9
2010
09:00:00
mmol/L
3.5-5.3
CL
Mar-17103
2010
09:00:00
mmol/L
98-110
CA
Mar-178.8
2010
09:00:00
mg/dL
8.6-10.2
GLU
Mar-1793
2010
09:00:00
mg/dL
70-100
BUN
Mar-1713
2010
09:00:00
mg/dL
7-25
CREAT
Mar-170.82
2010
09:00:00
mg/dL
0.50-1.20
Mar-1719
2010
09:00:00
U/L
9-60
Mar-1722
2010
09:00:00
U/L
10-35
Mar-1760
2010
09:00:00
U/L
40-115
Mar-170.5
2010
09:00:00
mg/dL
0.2-1.2
Mar-174.1
2010
09:00:00
g/dL
3.6-5.1
Mar-172010
x10(3) K/uL
3.8-11.0
7.3
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
09:00:00
RBC
Mar-174.38
2010
09:00:00
x10(6) M/uL
3.40-5.30
HGB
Mar-1713.5
2010
09:00:00
g/dL
10.9-14.7
HCT
Mar-1740.3
2010
09:00:00
33.0-43.0
MCV
Mar-1792.0
2010
09:00:00
fl
80.0-96.0
MCH
Mar-1730.8
2010
09:00:00
pg
26.0-34.0
MCHC
Mar-1733.5
2010
09:00:00
g/dL
31.0-36.0
PLT
Mar-17210
2010
09:00:00
x10(3) K/uL
140-400
LYM%
Mar-1731.4
2010
09:00:00
15.0-50.0
MID%
Mar-1710.0
2010
09:00:00
0.1-24.0
GRAN%
Mar-1758.6
2010
09:00:00
40.0-80.0
LYM
Mar-172.3
2010
09:00:00
x10(3) K/uL
1.0-4.2
MID
Mar-170.7
2010
09:00:00
x10(3) K/uL
0.0-1.8
GRAN
Mar-174.3
2010
09:00:00
x10(3) K/uL
1.3-8.8
RDW
Mar-1712.7
2010
09:00:00
11.0-16.0
Mar-1761
2010
09:00:00
mm/hr
0-20
PT
Feb-2421.2
2010
11:48:56
sec
INR
Feb-242.9
2010
11:48:56
Ratio
Feb-03-
sec
Panel Description:
Sedimentation Rate
SR
18.4
2010
12:02:00
INR
Feb-032.3
2010
12:02:00
Ratio
PT
Jan-1320.1
2010
10:10:14
sec
INR
Jan-132.6
2010
10:10:14
Ratio
PT
Dec-2318.8
2009
11:05:00
sec
INR
Dec-232.4
2009
11:05:00
Ratio
PT
Dec-0320.3
2009
09:44:46
sec
INR
Dec-032.7
2009
09:44:46
Ratio
CO2
Dec-0324.9
2009
09:44:46
mEq/L
21.0-33.0
NA
Dec-03136
2009
09:44:46
mmol/L
135-146
Dec-034.3
2009
09:44:46
mmol/L
3.5-5.3
CL
Dec-03100
2009
09:44:46
mmol/L
98-110
CA
Dec-039.6
2009
09:44:46
mg/dL
8.6-10.2
GLU
Dec-0388
2009
09:44:46
mg/dL
70-100
BUN
Dec-0312
2009
09:44:46
mg/dL
7-25
CREAT
Dec-030.79
2009
09:44:46
mg/dL
0.50-1.20
Dec-03154
2009
09:44:46
mg/dL
0-200
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
TRIG
Dec-0397
2009
09:44:46
mg/dL
0-250
HDL
Dec-0355
2009
09:44:46
mg/dL
>40
LDL
Dec-0380
2009
09:44:46
mg/dL
<130
C/HDL RATIO
Dec-032.8
2009
09:44:46
ratio
Dec-030.76
2009
09:44:46
ulU/mL
0.34-5.60
Dec-0323
2009
09:44:46
U/L
9-60
PT
Nov-12- 20.8
2009
11:35:00
sec
INR
Nov-12- 2.8
2009
11:35:00
Ratio
PT
Oct-2319.8
2009
11:09:46
sec
INR
Oct-232.6
2009
11:09:46
Ratio
PT
Oct-0118.3
2009
11:27:59
sec
INR
Oct-012.2
2009
11:27:59
Ratio
PT
Sep-1018.8
2009
11:52:14
sec
INR
Sep-102.4
2009
11:52:14
Ratio
PT
Aug-27- 22.4
2009
11:36:00
sec
INR
Aug-27- 3.3
2009
11:36:00
Ratio
Aug-06- 18.9
2009
11:27:18
sec
INR
Aug-06- 2.5
2009
11:27:18
Ratio
WBC
Jul-166.4
2009
10:39:54
x10(3) K/uL
3.8-11.0
RBC
Jul-164.27
2009
10:39:54
x10(6) M/uL
3.40-5.30
HGB
Jul-1612.9
2009
10:39:54
g/dL
10.9-14.7
HCT
Jul-1640.1
2009
10:39:54
33.0-43.0
MCV
Jul-1693.9
2009
10:39:54
fl
80.0-96.0
MCH
Jul-1630.2
2009
10:39:54
pg
26.0-34.0
MCHC
Jul-1632.2
2009
10:39:54
g/dL
31.0-36.0
PLT
Jul-16209
2009
10:39:54
x10(3) K/uL
140-400
LYM%
Jul-1639.5
2009
10:39:54
15.0-50.0
MID%
Jul-1610.3
2009
10:39:54
0.1-24.0
GRAN%
Jul-1650.2
2009
10:39:54
40.0-80.0
LYM
Jul-162.5
2009
10:39:54
x10(3) K/uL
1.0-4.2
MID
Jul-160.7
2009
10:39:54
x10(3) K/uL
0.0-1.8
GRAN
Jul-163.2
2009
10:39:54
x10(3) K/uL
1.3-8.8
RDW
Jul-1613.4
2009
10:39:54
11.0-16.0
Jul-162009
mm/hr
0-20
Panel Description:
Sedimentation Rate
SR
42
10:39:54
Panel Description: Protime
PT
Jul-1619.3
2009
10:39:54
sec
INR
Jul-162.5
2009
10:39:54
Ratio
WBC
Jun-266.3
2009
11:36:24
x10(3) K/uL
3.8-11.0
RBC
Jun-264.44
2009
11:36:24
x10(6) M/uL
3.40-5.30
HGB
Jun-2613.7
2009
11:36:24
g/dL
10.9-14.7
HCT
Jun-2641.0
2009
11:36:24
33.0-43.0
MCV
Jun-2692.3
2009
11:36:24
fl
80.0-96.0
MCH
Jun-2630.9
2009
11:36:24
pg
26.0-34.0
MCHC
Jun-2633.4
2009
11:36:24
g/dL
31.0-36.0
PLT
Jun-26222
2009
11:36:24
x10(3) K/uL
140-400
LYM%
Jun-2639.0
2009
11:36:24
15.0-50.0
MID%
Jun-269.0
2009
11:36:24
0.1-24.0
GRAN%
Jun-2652.0
2009
11:36:24
40.0-80.0
LYM
Jun-262.5
2009
11:36:24
x10(3) K/uL
1.0-4.2
MID
Jun-260.6
2009
11:36:24
x10(3) K/uL
0.0-1.8
GRAN
Jun-263.2
2009
11:36:24
x10(3) K/uL
1.3-8.8
RDW
Jun-2613.1
2009
11:36:24
11.0-16.0
Jun-252009
sec
18.8
10:21:32
INR
Jun-252.4
2009
10:21:32
Ratio
Jun-25Negative
2009
12:53:24
Negative
OCC BLD #2
Jun-25Positive
2009
12:53:24
Negative
OCC BLD #3
Jun-25Positive
2009
12:53:24
Negative
Jun-085.9
2009
10:53:00
x10(3) K/uL
3.8-11.0
RBC
Jun-084.29
2009
10:53:00
x10(6) M/uL
3.40-5.30
HGB
Jun-0813.4
2009
10:53:00
g/dL
10.9-14.7
HCT
Jun-0839.3
2009
10:53:00
33.0-43.0
MCV
Jun-0891.6
2009
10:53:00
fl
80.0-96.0
MCH
Jun-0831.2
2009
10:53:00
pg
26.0-34.0
MCHC
Jun-0834.1
2009
10:53:00
g/dL
31.0-36.0
PLT
Jun-08198
2009
10:53:00
x10(3) K/uL
140-400
LYM%
Jun-0833.4
2009
10:53:00
15.0-50.0
MID%
Jun-089.0
2009
10:53:00
0.1-24.0
GRAN%
Jun-0857.6
2009
10:53:00
40.0-80.0
LYM
Jun-082.0
2009
10:53:00
x10(3) K/uL
1.0-4.2
MID
Jun-080.5
2009
10:53:00
x10(3) K/uL
0.0-1.8
GRAN
Jun-082009
x10(3) K/uL
1.3-8.8
3.4
10:53:00
RDW
Jun-0813.4
2009
10:53:00
PT
Jun-0818.3
2009
10:53:00
sec
INR
Jun-082.3
2009
10:53:00
Ratio
PT
May-18- 19.4
2009
09:53:52
sec
INR
May-18- 2.5
2009
09:53:52
Ratio
11.0-16.0
May-18- Yellow
2009
09:53:52
APP
May-18- Clear
2009
09:53:52
GLUC
May-18- Negative
2009
09:53:52
Negative
BILI
May-18- Negative
2009
09:53:52
Negative
KET
May-18- Negative
2009
09:53:52
Negative
SG
May-18- <=1.005
2009
09:53:52
1.0001.030
pH
May-18- 7.0
2009
09:53:52
PROT
May-18- Negative
2009
09:53:52
NegativeTrace
UROBIL
May-18- 0.2
2009
E.U./dL
09:53:52
0.2-1.0
NIT
May-18- Negative
2009
09:53:52
Negative
BLD
May-18- 2+
2009
09:53:52
Negative
LEUK
May-18- Negative
2009
09:53:52
Negative
AMORPH
May-182009
None Seen
/hpf
09:53:52
EPI
May-18- 0-3
2009
09:53:52
None Seen
WBCU
May-18- 0-3
2009
09:53:52
None Seen
RBCU
May-18- 5-10
2009
09:53:52
None Seen
CAST
None Seen
BACT
None Seen
CRY
None Seen
MUC
May-18- Trace
2009
09:53:52
None Seen
OTHER
None Seen
May-18- 148
2009
09:53:52
mg/dL
0-200
TRIG
May-18- 94
2009
09:53:52
mg/dL
0-250
HDL
May-18- 48
2009
09:53:52
mg/dL
>40
LDL
May-18- 81
2009
09:53:52
mg/dL
<130
C/HDL RATIO
May-18- 3.1
2009
09:53:52
ratio
CO2
May-18- 26.3
2009
09:53:52
mEq/L
21.0-33.0
NA
May-18- 137
2009
09:53:52
mmol/L
135-146
May-18- 4.2
2009
09:53:52
mmol/L
3.5-5.3
CL
May-18- 102
2009
09:53:52
mmol/L
98-110
CA
May-182009
mg/dL
8.6-10.2
9.7
09:53:52
GLU
May-18- 90
2009
09:53:52
mg/dL
70-100
BUN
May-18- 12
2009
09:53:52
mg/dL
7-25
CREAT
May-18- 0.80
2009
09:53:52
mg/dL
0.50-1.20
May-18- 0.88
2009
09:53:52
ulU/mL
0.34-5.60
May-18- 24
2009
09:53:52
U/L
9-60
PT
Apr-2717.9
2009
11:45:00
sec
INR
Apr-272.2
2009
11:45:00
Ratio
PT
Apr-0618.4
2009
11:01:56
sec
INR
Apr-062.3
2009
11:01:56
Ratio
PT
Mar-1618.3
2009
11:40:20
sec
INR
Mar-162.1
2009
11:40:20
Ratio
PT
Feb-2318.3
2009
10:45:00
sec
INR
Feb-232.1
2009
10:45:00
Ratio
PT
Feb-0220.1
2009
10:50:00
sec
INR
Feb-022.5
2009
10:50:00
Ratio
Jan-12-
sec
19.1
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
2009
11:36:55
INR
Jan-122.3
2009
11:36:55
Ratio
PT
Dec-2220.0
2008
09:54:55
sec
INR
Dec-222.4
2008
09:54:55
Ratio
CO2
Dec-2227.4
2008
09:54:55
mEq/L
21.0-33.0
NA
Dec-22138
2008
09:54:55
mmol/L
135-146
Dec-224.2
2008
09:54:55
mmol/L
3.5-5.3
CL
Dec-22105
2008
09:54:55
mmol/L
98-110
CA
Dec-228.8
2008
09:54:55
mg/dL
8.6-10.2
GLU
Dec-2285
2008
09:54:55
mg/dL
70-100
BUN
Dec-2213
2008
09:54:55
mg/dL
7-25
CREAT
Dec-220.78
2008
09:54:55
mg/dL
0.50-1.20
WBC
Dec-226.6
2008
09:54:55
x10(3) K/uL
3.8-11.0
LYM
Dec-222.1
2008
09:54:55
x10(3) K/uL
1.0-4.2
LYM%
Dec-2232.5
2008
09:54:55
15.0-50.0
MID
Dec-220.4
2008
09:54:55
x10(3) K/uL
0.0-1.8
MID%
Dec-226.3
2008
09:54:55
0.1-24.0
GRAN
Dec-224.0
2008
09:54:55
x10(3) K/uL
1.3-8.8
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
GRAN%
Dec-2261.2
2008
09:54:55
40.0-80.0
RBC
Dec-224.33
2008
09:54:55
x10(6) M/uL
3.40-5.30
HGB
Dec-2213.1
2008
09:54:55
g/dL
10.9-14.7
HCT
Dec-2239.1
2008
09:54:55
33.0-43.0
MCV
Dec-2290.3
2008
09:54:55
fl
80.0-96.0
MCH
Dec-2230.3
2008
09:54:55
pg
26.0-34.0
MCHC
Dec-2233.5
2008
09:54:55
g/dL
31.0-36.0
RDW
Dec-2212.6
2008
09:54:55
11.0-16.0
PLT
Dec-22209
2008
09:54:55
x10(3) K/uL
140-400
CHOL
Dec-22135
2008
09:54:55
mg/dL
0-200
TRIG
Dec-2265
2008
09:54:55
mg/dL
0-250
HDL
Dec-2249
2008
09:54:55
mg/dL
>40
LDL
Dec-2273
2008
09:54:55
mg/dL
<130
C/HDL RATIO
Dec-222.8
2008
09:54:55
ratio
Dec-2219
2008
09:54:55
U/L
PT
Dec-0120.4
2008
11:42:57
sec
INR
Dec-012.5
2008
11:42:57
Ratio
Nov-172008
sec
16.3
9-60
11:20:31
INR
Nov-17- 1.7
2008
11:20:31
Ratio
PT
Oct-2717.9
2008
11:30:01
sec
INR
Oct-272.0
2008
11:30:01
Ratio
PT
Oct-1316.2
2008
09:30:42
sec
INR
Oct-131.7
2008
09:30:42
Ratio
PT
Sep-2417.7
2008
11:40:00
sec
INR
Sep-242.0
2008
11:40:00
Ratio
PT
Sep-0317.6
2008
09:00:54
sec
INR
Sep-032.0
2008
09:00:54
Ratio
Panel Description:
METHYLENETETRAHYDROFOLATE
REDUCTASE (MTHFR)
85986610
Aug-222008
15:03:32
RESULT: POSITIVE FOR ONE COPY OF THE A1298C MUTATION
 
 DNA testing indicates this
individual is heterozygous for
 the A1298C mutation and does not have the C677T mutation.
The presence of one copy of the A1298C mutation has not been
 associated with an increased risk
for hyperhomocysteinemia
 or vascular diseases. Consider genetic counseling and DNA
testing for at-risk family members.
 
 Laboratory testing supervised and results monitored
by
 Charles Strom, M.D., Ph.D., FACMG, FAAP, HCLD.
 Hyperhomocysteinemia is a risk factor
for arterial disease
 and venous thrombosis. Homocysteine levels are affected by
 nutritional
and genetic factors. Since MTHFR is involved in
 methylation of homocysteine to methionine,
individuals with
 MTHFR gene mutations that reduce enzyme activity may develop
hyperhomocysteinemia and thus be at elevated risk for
 vascular disease.
 
 The
C677T and A1298C mutations are detected by amplification
 of the MTHFR gene by polymerase
chain reaction (PCR)
 followed by an oligonucleotide ligation assay (OLA). The
 biotinylated
extension products are then hybridized on
 microspheres and detected by the identity of the
microspheres as well as the reporter fluorescence. Since
 genetic variation and other factors can
affect the accuracy
 of direct mutation testing, these results should be
 interpreted in light of
clinical and familial data.
 
 This test was developed and its performance
characteristics
 have been determined by Quest Diagnostics Nichols Institute,
 San Juan
Capistrano. It has not been cleared or approved by
 the U.S. Food and Drug Administration. The
FDA has
 determined that such clearance or approval is not necessary.
 Performance
characteristics refer to the analytical
 performance of the test.
86002085
Aug-222008
15:03:32
PERFORMED
PT
Aug-18- 27.1
2008
10:12:27
sec
INR
Aug-18- 4.3
2008
10:12:27
Ratio
CHOL
Aug-18- 150
2008
10:12:27
mg/dL
0-200
TRIG
Aug-18- 129
2008
10:12:27
mg/dL
0-250
HDL
Aug-18- 38
2008
10:12:27
mg/dL
>40
LDL
Aug-18- 86
2008
10:12:27
mg/dL
<130
C/HDL RATIO
Aug-18- 3.9
2008
10:12:27
ratio
CO2
Aug-18- 22.3
2008
Results
10:12:27 verified by
repeat
analysis
mEq/L
23.0-29.0
NA
Aug-18- 140
2008
10:12:27
mmol/L
136-145
Aug-18- 4.4
2008
10:12:27
mmol/L
3.5-5.3
CL
Aug-18- 104
2008
10:12:27
mmol/L
97-110
GLU
Aug-18- 84
2008
10:12:27
mg/dL
70-100
CREAT
Aug-18- 0.9
2008
10:12:27
mg/dL
0.6-1.2
CA
Aug-18- 9.3
2008
10:12:27
mg/dL
8.5-10.5
BUN
Aug-18- 13
2008
10:12:27
mg/dL
7-27
CGFR
Aug-18- >=60
2008
10:12:27
mL/min/1.73m
2
>60
Aug-182008
umol/L
<10.4
HH
Panel Description:
HOMOCYSTEINE,
CARDIOVASCULAR
HOMOCYSTEINE,
CARDIOVASCULAR
5.1
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
If the patient is African-American, please multiply the result by 1.21. This result has been calculated
assuming the patient is non-African-American
10:12:27
Panel Description: LUPUS
ANTICOAGULANT W/ REFLEX
LUPUS ANTICOAGULANT
NOT
DETECTED

 A LUPUS ANTICOAGULANT IS DETECTED SINCE ONE
 OF THE TWO CONFIRMATORY TESTS
IS POSITIVE. 
 
 LUPUS ANTICOAGULANTS (LA) MAY BE ASSOCIATED WITH 
THROMBOTIC EVENTS, RECURRENT ABORTION, OR MAY BE
 ASYMPTOMATIC. A BLEEDING
HISTORY REQUIRES OTHER
 COAGULOPATHIES BE EXCLUDED. SINCE LA MAY BE
TRANSIENT,
 INTERNATIONAL CONSENSUS GUIDELINES SUGGEST WAITING AT 
 LEAST 12
WEEKS BEFORE RETESTING TO CONFIRM ANTIBODY
 PERSISTENCE. (J THROMB HAEMOST 2006:
4; 295).
 
 THIS INTERPRETATION IS BASED ON THE
 FOLLOWING TEST
RESULTS:
PTT-LA SCREEN
Aug-18- 55
2008
10:12:27
sec
< OR = 40
DRVVT SCREEN
Aug-18- 53
2008
10:12:27
sec
< OR = 42
Aug-18- NEGATIVE
2008
10:12:27
NEGATIVE
Aug-18- <20
2008
10:12:27
IU/mL
<20
THYROID PEROXIDASE
ANTIBODIES
Aug-18- 79
2008
10:12:27
IU/mL
<35
B2-GLYCOPROTEIN I (IGG) AB
Aug-18- <20
2008
10:12:27
U/mL
<20

 Patients who are found to be anticardiolipin
 antibody positive may have negative studies
to
 Beta 2 GPI. Positive anticardiolipin antibody
 tests together with negative testing
for
 antibodies to Beta 2 GPI may be seen in a variety
 of different clinical settings
including
 convalescence from recent infections (viral or
 bacterial).
B2-GLYCOPROTEIN I (IGM) AB
Aug-18- <10
2008
10:12:27
U/mL
<10

 Patients who are found to be anticardiolipin
 antibody positive may have negative studies
to
 Beta 2 GPI. Positive anticardiolipin antibody
 tests together with negative testing
for
 antibodies to Beta 2 GPI may be seen in a variety
 of different clinical settings
including
 convalescence from recent infections (viral or
 bacterial).
B2-GLYCOPROTEIN I (IGA) AB
Aug-18- <10
2008
10:12:27
U/mL
<10

 Patients who are found to be anticardiolipin
 antibody positive may have negative studies
to
 Beta 2 GPI. Positive anticardiolipin antibody
 tests together with negative testing
for
 antibodies to Beta 2 GPI may be seen in a variety
 of different clinical settings
including
 convalescence from recent infections (viral or
 bacterial).
Aug-18- TNP
2008
10:12:27
mg/dL
PT
Aug-04- 23.3
2008
11:06:34
sec
INR
Aug-04- 3.3
2008
11:06:34
Ratio
WBC
Aug-04- 9.0
2008
11:06:34
x10(3) K/uL
3.8-11.0
LYM
Aug-04- 3.6
2008
11:06:34
x10(3) K/uL
1.0-4.2
LYM%
Aug-04- 39.7
2008
11:06:34
15.0-50.0
MID
Aug-04- 0.7
2008
11:06:34
x10(3) K/uL
0.0-1.8
MID%
Aug-04- 7.3
2008
11:06:34
0.1-24.0
GRAN
Aug-04- 4.8
2008
11:06:34
x10(3) K/uL
1.3-8.8
GRAN%
Aug-04- 53.0
2008
11:06:34
40.0-80.0
RBC
Aug-04- 4.54
2008
11:06:34
x10(6) M/uL
3.40-5.30
HGB
Aug-04- 13.5
2008
11:06:34
g/dL
10.9-14.7
HCT
Aug-04- 39.9
2008
11:06:34
33.0-43.0
MCV
Aug-04- 87.9
2008
11:06:34
fl
80.0-96.0
MCH
Aug-04- 29.7
2008
11:06:34
pg
26.0-34.0
MCHC
Aug-04- 33.8
2008
11:06:34
g/dL
31.0-36.0
RDW
Aug-04- 13.6
2008
11:06:34
11.0-16.0
PLT
Aug-04- 210
2008
11:06:34
x10(3) K/uL
140-400
Aug-04- 50
2008
11:06:34
ng/mL
20-100
VITAMIN D, 25-OH, D3
Aug-04- 50
2008
11:06:34
ng/mL
VITAMIN D, 25-OH, D2
Aug-04- <4
2008
11:06:34
ng/mL
Panel Description:
Sedimentation Rate
SR
Aug-04- 66
2008
11:06:34
mm/hr
0-20
Aug-04- 0.9
2008
11:06:34
mg/dL
0.6-1.2
Aug-04- 9.5
2008
11:06:34
mg/dL
8.5-10.5
Aug-04- 29
2008
11:06:34
U/L
10-40
Aug-04- 33
2008
11:06:34
U/L
5-34
Aug-04- 76
2008
11:06:34
U/L
35-123
Aug-04- 0.6
2008
11:06:34
mg/dL
0.2-1.0
PROTEIN, TOTAL
Aug-04- 7.8
2008
11:06:34
g/dL
6.2-8.3
ALBUMIN
Aug-04- 3.6
2008
11:06:34
g/dL
3.5-4.7
ALPHA-1-GLOBULINS
Aug-04- 0.3
2008
11:06:34
g/dL
0.1-0.3
ALPHA-2-GLOBULINS
Aug-04- 1.0
2008
11:06:34
g/dL
0.5-1.0
BETA GLOBULINS
Aug-04- 1.3
2008
11:06:34
g/dL
0.8-1.4
GAMMA GLOBULINS
Aug-04- 1.5
2008
11:06:34
g/dL
0.6-1.6
INTERPRETATION
NORMAL PATTERN
PT
Jul-1419.9
2008
09:26:08
sec
INR
Jul-142.4
2008
09:26:08
Ratio
PT
Jun-2318.8
2008
10:45:02
sec
INR
Jun-232.2
2008
10:45:02
Ratio
PT
Jun-0220.0
2008
11:15:22
sec
INR
Jun-022.5
2008
11:15:22
Ratio
PT
May-12- 19.7
2008
11:59:19
sec
INR
May-12- 2.4
2008
11:59:19
Ratio
May-05- Negative
2008
15:10:22
Negative
OCC BLD #2
May-05- Negative
2008
15:10:22
Negative
OCC BLD #3
May-05- Negative
2008
15:10:22
Negative
Apr-2519.3
2008
09:46:47
sec
INR
Apr-252.3
2008
09:46:47
Ratio
CHOL
Apr-25155
2008
09:46:47
mg/dL
0-200
TRIG
Apr-25123
2008
09:46:47
mg/dL
0-250
HDL
Apr-2548
2008
09:46:47
mg/dL
>40
LDL
Apr-25-
mg/dL
<130
82
2008
09:46:47
C/HDL RATIO
Apr-253.2
2008
09:46:47
ratio
CO2
Apr-2523.2
2008
09:46:47
mEq/L
23.0-29.0
NA
Apr-25140
2008
09:46:47
mmol/L
136-145
Apr-254.3
2008
09:46:47
mmol/L
3.5-5.3
CL
Apr-25105
2008
09:46:47
mmol/L
97-110
GLU
Apr-2595
2008
09:46:47
mg/dL
70-100
CREAT
Apr-250.8
2008
09:46:47
mg/dL
0.6-1.2
CA
Apr-259.0
2008
09:46:47
mg/dL
8.5-10.5
BUN
Apr-2516
2008
09:46:47
mg/dL
7-27
CGFR
Apr-25>=60
2008
09:46:47
mL/min/1.73m
2
>60
Apr-2528
2008
09:46:47
U/L
10-40
Apr-250.87
2008
09:46:47
ulU/mL
0.47-5.01
WBC
Apr-255.8
2008
09:46:47
x10(3) K/uL
3.8-11.0
LYM
Apr-252.3
2008
09:46:47
x10(3) K/uL
1.0-4.2
LYM%
Apr-2539.1
2008
09:46:47
15.0-50.0
MID
Apr-250.4
2008
09:46:47
x10(3) K/uL
0.0-1.8
MID%
Apr-252008
0.1-24.0
7.7
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
If the patient is African-American, please multiply the result by 1.21. This result has been calculated
assuming the patient is non-African-American
09:46:47
GRAN
Apr-253.1
2008
09:46:47
x10(3) K/uL
1.3-8.8
GRAN%
Apr-2553.2
2008
09:46:47
40.0-80.0
RBC
Apr-254.52
2008
09:46:47
x10(6) M/uL
3.40-5.30
HGB
Apr-2513.5
2008
09:46:47
g/dL
10.9-14.7
HCT
Apr-2541.1
2008
09:46:47
33.0-43.0
MCV
Apr-2590.9
2008
09:46:47
fl
80.0-96.0
MCH
Apr-2529.9
2008
09:46:47
pg
26.0-34.0
MCHC
Apr-2532.8
2008
09:46:47
g/dL
31.0-36.0
RDW
Apr-2513.3
2008
09:46:47
11.0-16.0
PLT
Apr-25212
2008
09:46:47
x10(3) K/uL
140-400
MPV
Apr-2511.4
2008
09:46:47
fl
Apr-2526
2008
09:46:47
ng/mL
PT
Apr-0418.5
2008
10:54:26
sec
INR
Apr-042.2
2008
10:54:26
Ratio
PT
Mar-1118.1
2008
09:49:00
sec
INR
Mar-112.1
2008
09:49:00
Ratio
Feb-1820.4
2008
11:11:11
sec
20-288
INR
Feb-182.6
2008
11:11:11
Ratio
Feb-180.23
2008
11:11:11
IU/mL
PT
Jan-2516.6
2008
10:29:45
sec
INR
Jan-252.0
2008
10:29:45
Ratio
PT
Jan-0416.2
2008
11:50:17
sec
INR
Jan-042.0
2008
11:50:17
Ratio
PT
Dec-1116.9
2007
10:57:38
sec
INR
Dec-112.1
2007
10:57:38
Ratio
WBC
Nov-20- 7.2
2007
10:28:36
x10(3) K/uL
3.8-11.0
LYM
Nov-20- 3.1
2007
10:28:36
x10(3) K/uL
1.0-4.2
LYM%
Nov-20- 42.8
2007
10:28:36
15.0-50.0
MID
Nov-20- 0.4
2007
10:28:36
x10(3) K/uL
0.0-1.8
MID%
Nov-20- 5.1
2007
10:28:36
0.1-24.0
GRAN
Nov-20- 3.8
2007
10:28:36
x10(3) K/uL
1.3-8.8
>0.15
Inst.Flags
Nov-20- 0.0
2007
10:28:36
GRAN%
Nov-20- 52.1
2007
10:28:36
40.0-80.0
RBC
Nov-20- 4.52
2007
10:28:36
x10(6) M/uL
3.40-5.30
HGB
Nov-20- 13.7
2007
10:28:36
g/dL
10.9-14.7
HCT
Nov-20- 40.6
2007
10:28:36
33.0-43.0
MCV
Nov-20- 89.9
2007
10:28:36
fl
80.0-96.0
MCH
Nov-20- 30.3
2007
10:28:36
pg
26.0-34.0
MCHC
Nov-20- 33.7
2007
10:28:36
g/dL
31.0-36.0
RDW
Nov-20- 13.6
2007
10:28:36
11.0-16.0
PLT
Nov-20- 174
2007
10:28:36
x10(3) K/uL
140-400
MPV
Nov-20- 12.5
2007
10:28:36
fl
Nov-20- 26
2007
10:28:36
U/L
10-40
Nov-20- 1.44
2007
10:28:36
ulU/mL
0.47-5.01
CHOL
Nov-20- 181
2007
10:28:36
mg/dL
0-200
TRIG
Nov-20- 104
2007
10:28:36
mg/dL
0-250
HDL
Nov-20- 50
2007
10:28:36
mg/dL
>40
VLDL
Nov-20- 21
2007
10:28:36
LDL
Nov-20- 110
2007
10:28:36
mg/dL
<130
C/HDL RATIO
Nov-20- 3.6
2007
10:28:36
ratio
CO2
Nov-20- 24.1
2007
10:28:36
mEq/L
23.0-29.0
NA
Nov-20- 139
2007
10:28:36
mmol/L
136-145
Nov-20- 4.4
2007
10:28:36
mmol/L
3.5-5.3
CL
Nov-20- 104
2007
10:28:36
mmol/L
97-110
GLU
Nov-20- 98
2007
10:28:36
mg/dL
70-100
CREAT
Nov-20- 0.8
2007
10:28:36
mg/dL
0.6-1.2
CA
Nov-20- 8.6
2007
10:28:36
mg/dL
8.5-10.5
BUN
Nov-20- 15
2007
10:28:36
mg/dL
7-27
CGFR
Nov-20- 75.55
2007
10:28:36
mL/min/1.73m
2
>60.00
If the patient is African-American, please multiply the result by 1.21. This result has been calculated
assuming the patient is non-African-American
PT
Nov-20- 18.3
2007
10:28:36
sec
INR
Nov-20- 2.5
2007
10:28:36
Ratio
Nov-20- <3
2007
10:28:36
U/mL
<5

 Reference range:
 <5 U/mL Negative
 5-8 U/mL Equivocal
 >8 U/mL
Positive
Nov-20- 6
2007
10:28:36
U/mL
<11

 Reference Range:
 <11 U/mL Negative
 11-17 U/mL Equivocal
 >17 U/mL
Positive
IGA, SERUM
Nov-20- 584
2007
10:28:36
mg/dL
81-463
PT
Oct-2916.8
2007
11:34:47
sec
INR
Oct-292007
Ratio
Normal Fasting Glucose: 70-100
 Impaired Fasting Glucse: 101-125
 Diagnostic for Diabetes:
>=126
2.1
11:34:47
Advance Directives
Directive
Yes / No
Effective Date
File Name
Unknown
WARNING:The information contained in this section is historical and is provided for information only and does not constitute a legal document or any assurance that the information is still accurate. Please verify the
information with the holder of the legal document before using it for clinical purposes.
Encounters
Encounter
Practice
Location
Diagnoses
Unknown
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Masland
Associates
Inc
Date
Provider
Sep082014
Sep052014
Sep022014
Aug052014
Jul242014
Jul152014
Masland
Associates
Inc
Masland
Associates
Inc
6 month
follow-up
weight (chief
complaint)
PURE
HYPERCHOLESTEROLEM
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Jun252014
Unknown
Masland
Associates
Inc
Jun192014
Masland
Associates
Inc
Jun172014
PURE
HYPERCHOLESTEROLEM
FLU W RESP MANIFEST
NEC
Masland
Associates
Inc
(chief complaint)
Masland
Associates
Inc
Abnormal Cardiac
Enzymes
HEMOLYTIC ANEMIA NOS
CAD, Native Vessel
Jun122014
May272014
Unknown
May232014
Unknown
May142014
Masland
Associates
Inc
May122014
Masland
Associates
Inc
Apr282014
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Apr142014
Apr142014
Mar192014
Mar182014
Mar142014
Feb172014
(chief complaint)
Unknown
Unknown
Masland
Associates
Inc
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Feb142014
Masland
Associates
Inc
Feb042014
Unknown
Masland
Associates
Inc
Jan282014
Unknown
Masland
Associates
Inc
Jan202014
Masland
Associates
Inc
Jan062014
Unknown
Masland
Associates
Inc
Jan032014
Unknown
Masland
Associates
Inc
Masland
Associates
Inc
4-5 month
knee pain
(chief
complaint)
Hypothyroidism
Hypercholesterolemia
OVERWEIGHT
LOC PRIM OSTEOARTL/LEG
Rheumatic Mitral Stenosis
& Aortic Stenosis
Dec312013
Dec272013
Masland
Associates
Inc
Dec232013
Masland
Associates
Inc
Dec182013
Masland
Associates
Inc
Nov192013
Masland
Associates
Inc
Oct222013
Unknown
Masland
Associates
Inc
Sep242013
Masland
Associates
Inc
Sep032013
Masland
Associates
Inc
Aug132013
(chief complaint)
5 month
follow-up
overweight
(chief
complaint)
Hypothyroidism
Hypercholesterolemia
OVERWEIGHT
S/P Valve Replacement
BACK DISORDER NOS
Masland
Associates
Inc
Aug062013
Unknown
Masland
Associates
Inc
Jul152013
Masland
Associates
Inc
Jul112013
Masland
Associates
Inc
Jun132013
Masland
Associates
Inc
May162013
Unknown
May092013
Unknown
Masland
Associates
Inc
Apr242013
Masland
Associates
Inc
Apr232013
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Unknown
Unknown
(chief complaint)
Apr192013
Masland
Associates
Inc
Apr192013
Masland
Associates
Inc
Apr112013
Unknown
Masland
Associates
Inc
Apr102013
Masland
Associates
Inc
Apr022013
Unknown
Masland
Associates
Inc
Apr012013
Masland
Associates
Inc
Mar122013
4 month
follow-up
back pain
(chief
complaint)
CONSTIPATION NOS
Masland
Associates
Inc
Feb212013
Unknown
Masland
Associates
Inc
Feb132013
Masland
Associates
Inc
Feb122013
Unknown
Masland
Associates
Inc
Feb112013
Masland
Associates
Inc
Feb072013
Unknown
Masland
Associates
Inc
Jan182013
Unknown
Jan152013
Unknown
Jan152013
Unknown
Masland
Associates
Inc
Jan112013
Unknown
Masland
Associates
Inc
Jan082013
Masland
Associates
Dec27-
(chief complaint)
(chief complaint)
Asthma
Bronchitis, Acute
CAD, Native Vessel
Inc
Level One Est Patient
Masland
Associates
Inc
Masland
Associates
Inc
Masland
Associates
Inc
Unknown
Unknown
2012
Dec122012
Dec062012
Nov152012
Masland
Associates
Inc
Nov132012
Masland
Associates
Inc
Oct232012
Masland
Associates
Inc
Oct222012
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Oct182012
Oct162012
Oct022012
Oct022012
BP check
tdap
(chief complaint)
(chief complaint)
Hypothyroidism
Hypercholesterolemia
S/P Valve Replacement
OVERWEIGHT
Osteoporosis
Upper Respiratory
Infection, Acute
S/P Valve Replacement
Unknown
Unknown
Unknown
Masland
Associates
Inc
Sep262012
Masland
Associates
Inc
Sep112012
Unknown
Masland
Associates
Inc
Aug292012
Masland
Associates
Inc
Aug282012
Masland
Associates
Inc
Aug142012
Unknown
Jul232012
Jul182012
Masland
Associates
Inc
Masland
Associates
Inc
Masland
Associates
Inc
(chief complaint)
Thrombocytopenia
Hypothyroidism
Hypercholesterolemia
DIFF CONNECTIVE TISS
DIS
Rheumatic Mitral Stenosis
& Aortic Stenosis
Jul122012
Unknown
Masland
Associates
Inc
Jul112012
Masland
Associates
Inc
Jun282012
Masland
Associates
Inc
Jun132012
Masland
Associates
Inc
May302012
Masland
Associates
Inc
May232012
Masland
Associates
Inc
May022012
Unknown
Masland
Associates
Inc
Apr272012
Unknown
Masland
Associates
Inc
Apr252012
Masland
Associates
Inc
Apr232012
(chief complaint)
NEUROPATHY IN OTHER
DIS
MITRAL/AORTIC
STENOSIS
CRNRY ATHRSCL NATVE
VSSL
BACK DISORDER NOS
CRNRY ATHRSCL NATVE
VSSL
BACK DISORDER NOS
MITRAL/AORTIC
STENOSIS
NEUROPATHY IN OTHER
DIS
Unknown
Masland
Associates
Inc
Apr202012
Masland
Apr-
Associates
Inc
162012
Unknown
Masland
Associates
Inc
Apr142012
Masland
Associates
Inc
Apr132012
Unknown
Masland
Associates
Inc
Mar282012
Masland
Associates
Inc
Mar232012
Unknown
Masland
Associates
Inc
Mar222012
Masland
Associates
Inc
Mar082012
(chief complaint)
MITRAL/AORTIC
STENOSIS
NEUROPATHY IN OTHER
DIS
BACK DISORDER NOS
PURE
HYPERCHOLESTEROLEM
CRNRY ATHRSCL NATVE
VSSL
CRNRY ATHRSCL NATVE
VSSL
PURE
HYPERCHOLESTEROLEM
MITRAL/AORTIC
STENOSIS
BACK DISORDER NOS
OVERWEIGHT
Masland
Associates
Inc
Mar022012
Masland
Associates
Inc
Feb102012
Unknown
Masland
Associates
Inc
Feb092012
Unknown
Masland
Associates
Inc
Jan192012
Unknown
Masland
Associates
Inc
Jan132012
Masland
Associates
Inc
Jan122012
MITRAL/AORTIC
STENOSIS
BACK DISORDER NOS
CRNRY ATHRSCL NATVE
VSSL
HYPOTHYROIDISM NOS
MITRAL/AORTIC
STENOSIS
HYPOTHYROIDISM NOS
CRNRY ATHRSCL NATVE
VSSL
Unknown
Masland
Associates
Inc
Jan062012
Masland
Associates
Inc
Jan032012
Unknown
Masland
Associates
Inc
Dec302011
Masland
Associates
Inc
Dec272011
Dec232011
Dec092011
(chief complaint)
Unknown
MITRAL/AORTIC
STENOSIS
CRNRY ATHRSCL NATVE
VSSL
HYPOTHYROIDISM NOS
MITRAL/AORTIC
STENOSIS
CRNRY ATHRSCL NATVE
VSSL
BACTERIAL PNEUMONIA
NOS
HYPOTHYROIDISM NOS
Masland
Associates
Inc
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Dec072011
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Dec062011
Unknown
Masland
Associates
Inc
Dec012011
Masland
Associates
Inc
Nov232011
Masland
Associates
Inc
Nov172011
(chief complaint)
MITRAL/AORTIC
STENOSIS
MITRAL/AORTIC
STENOSIS
DIFF CONNECTIVE TISS
DIS
EPILEPSY
MITRAL/AORTIC
STENOSIS
EPILEPSY
DIFF CONNECTIVE TISS
DIS
Unknown
Masland
Associates
Inc
Nov112011
Masland
Associates
Inc
Nov022011
Unknown
Masland
Oct-
Associates
Inc
252011
Unknown
Masland
Associates
Inc
Oct242011
Masland
Associates
Inc
Oct112011
Unknown
Masland
Associates
Inc
Oct092011
Masland
Associates
Inc
Sep212011
Masland
Associates
Inc
Aug312011
Masland
Associates
Inc
Aug262011
(chief complaint)
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
HYPOTHYROIDISM NOS
ATHEROSCLEROSIS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
ATHEROSCLEROSIS
HYPOTHYROIDISM NOS
Masland
Associates
Inc
Aug102011
Masland
Associates
Inc
Jul202011
Masland
Associates
Inc
Jul012011
Masland
Associates
Inc
Jun102011
Masland
Associates
Inc
May252011
Unknown
Masland
Associates
Inc
May112011
Masland
Associates
Inc
May042011
Masland
Associates
Inc
Apr132011
Unknown
Masland
Associates
Inc
Apr052011
Unknown
Masland
Mar-
Associates
Inc
282011
Masland
Associates
Inc
Mar232011
Masland
Associates
Inc
Mar022011
Masland
Associates
Inc
Feb242011
(chief complaint)
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
HYPOTHYROIDISM NOS
OSTEOPOROSIS NOS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
EPILEPSY
HYPOTHYROIDISM NOS
OSTEOPOROSIS NOS
Masland
Associates
Inc
Feb092011
Masland
Associates
Inc
Jan202011
Unknown
Masland
Associates
Inc
Jan072011
Masland
Associates
Inc
Dec292010
Masland
Associates
Inc
Dec082010
Masland
Associates
Inc
Nov172010
Unknown
Masland
Associates
Inc
Nov032010
Masland
Associates
Inc
Oct272010
Masland
Associates
Inc
Oct062010
Unknown
Masland
Associates
Inc
Sep302010
Masland
Associates
Inc
Sep302010
(chief complaint)
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
BACK DISORDER NOS
PURE
HYPERCHOLESTEROLEM
Masland
Associates
Inc
Unknown
(chief complaint)
HYPOTHYROIDISM NOS
BACK DISORDER NOS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
HYPOTHYROIDISM NOS
SEBORRHEIC KERATOSIS
Sep232010
Masland
Associates
Inc
Sep232010
Masland
Associates
Inc
Sep152010
Masland
Associates
Inc
Aug242010
Masland
Associates
Inc
Aug032010
Masland
Associates
Inc
Jul132010
Masland
Associates
Inc
Jun222010
Masland
Associates
Inc
Jun012010
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
May262010
Masland
Associates
Inc
May242010
Unknown
Masland
Associates
Inc
May202010
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
May132010
Masland
Associates
Inc
May122010
Unknown
Masland
Associates
Inc
Apr232010
Masland
Associates
Inc
Apr212010
Masland
Associates
Inc
Apr122010
(chief complaint)
(chief complaint)
(chief complaint)
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
DIFF CONNECTIVE TISS
DIS
HYPOTHYROIDISM NOS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
DIFF CONNECTIVE TISS
DIS
HYPOTHYROIDISM NOS
SKIN ANOMALY NEC
Masland
Associates
Inc
Apr072010
Unknown
Masland
Associates
Inc
Mar282010
Unknown
Masland
Associates
Inc
Mar262010
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Mar232010
Unknown
Masland
Associates
Inc
Mar232010
Masland
Associates
Inc
Mar172010
Unknown
Masland
Associates
Inc
Mar152010
Masland
Associates
Inc
Feb242010
Masland
Associates
Inc
Feb032010
Unknown
Masland
Associates
Inc
Jan242010
Masland
Associates
Inc
Jan132010
Masland
Associates
Inc
Dec232009
Masland
Associates
Inc
Dec142009
back pain
Back pain
(chief
complaint)
(chief complaint)
SPRAIN THORACIC
REGION
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
PURE
HYPERGLYCERIDEMIA
HYPOTHYROIDISM NOS
ACTINIC KERATOSIS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
PURE
HYPERGLYCERIDEMIA
HYPOTHYROIDISM NOS
Masland
Associates
Inc
Dec032009
Masland
Associates
Inc
Nov122009
Unknown
Masland
Associates
Inc
Nov022009
Masland
Associates
Inc
Oct232009
Unknown
Masland
Associates
Inc
Oct222009
Masland
Associates
Inc
Oct012009
Masland
Associates
Inc
Sep102009
Masland
Associates
Inc
Aug272009
Masland
Associates
Inc
Aug062009
Masland
Associates
Inc
Jul162009
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Jul062009
Unknown
Masland
Associates
Inc
Jun262009
Unknown
Masland
Associates
Inc
Jun262009
Masland
Associates
Inc
Jun252009
Masland
Associates
Inc
Jun082009
(chief complaint)
(chief complaint)
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
NEUROPATHY IN OTHER
DIS
PURE
HYPERCHOLESTEROLEM
HYPOTHYROIDISM NOS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
NEUROPATHY IN OTHER
DIS
HYPOTHYROIDISM NOS
RECTAL & ANAL
HEMORRHAGE
OSTEOPOROSIS NOS
Unknown
Masland
Associates
Inc
Jun022009
Masland
Associates
Inc
May182009
Masland
Associates
Inc
Apr272009
Unknown
Masland
Associates
Inc
Apr242009
Masland
Associates
Inc
Apr062009
Masland
Associates
Inc
Mar162009
Unknown
Masland
Associates
Inc
Mar112009
Unknown
Masland
Associates
Inc
Mar092009
Masland
Associates
Inc
Feb232009
Unknown
Masland
Associates
Inc
Feb122009
Masland
Associates
Inc
Feb022009
Unknown
Masland
Associates
Inc
Jan202009
Masland
Associates
Inc
Jan122009
(chief complaint)
OVERWEIGHT
MITRAL/AORTIC
STENOSIS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
NEUROPATHY IN OTHER
DIS
MITRAL/AORTIC
STENOSIS
OVERWEIGHT
PURE
HYPERCHOLESTEROLEM
NEUROPATHY IN OTHER
DIS
Masland
Associates
Inc
Dec222008
Unknown
Masland
Associates
Inc
Dec192008
Masland
Associates
Inc
Dec012008
Unknown
Masland
Associates
Inc
Nov262008
Masland
Associates
Inc
Nov172008
Unknown
Masland
Associates
Inc
Nov062008
Unknown
Masland
Associates
Inc
Nov032008
Unknown
Masland
Associates
Inc
Oct292008
Unknown
Masland
Associates
Inc
Oct282008
Masland
Associates
Inc
Oct272008
Masland
Associates
Inc
Oct132008
Unknown
Masland
Associates
Inc
Oct102008
Masland
Associates
Inc
Sep242008
Masland
Associates
Inc
Sep032008
(chief complaint)
(chief complaint)
Unknown
Masland
Associates
Inc
Aug222008
Masland
Associates
Inc
Aug182008
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Unknown
Unknown
(chief complaint)
Aug152008
Aug042008
Jul312008
Masland
Associates
Inc
Jul302008
Masland
Associates
Inc
Jul232008
Masland
Associates
Inc
Jul142008
Masland
Associates
Inc
Jun232008
Masland
Associates
Inc
Jun022008
Masland
Associates
Inc
May122008
May082008
May052008
(chief complaint)
(chief complaint)
HYPOTHYROIDISM NOS
DIFF CONNECTIVE TISS
DIS
PURE
HYPERGLYCERIDEMIA
PURE
HYPERCHOLESTEROLEM
NEUROPATHY IN OTHER
DIS
PURE
HYPERCHOLESTEROLEM
NEUROPATHY IN OTHER
DIS
DIFF CONNECTIVE TISS
DIS
HYPOTHYROIDISM NOS
Unknown
Masland
Associates
Inc
Unknown
Masland
Associates
Inc
Apr252008
Unknown
Masland
Associates
Inc
Apr212008
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Apr042008
Unknown
Masland
Associates
Inc
Mar282008
Masland
Mar-
(chief complaint)
(chief complaint)
Associates
Inc
NEUROPATHY IN OTHER
DIS
BENIGN HYPERTENSION
202008
Masland
Associates
Inc
Mar112008
Unknown
Masland
Associates
Inc
Mar042008
Masland
Associates
Inc
Feb182008
Masland
Associates
Inc
Feb082008
Masland
Associates
Inc
Jan252008
Masland
Associates
Inc
Jan042008
Masland
Associates
Inc
Dec282007
Unknown
Masland
Associates
Inc
Dec182007
Masland
Associates
Inc
Dec112007
Unknown
Masland
Associates
Inc
Dec102007
Masland
Associates
Inc
Nov272007
Masland
Associates
Inc
Nov202007
Unknown
Masland
Associates
Inc
Nov152007
Masland
Associates
Inc
Oct292007
Unknown
Masland
Associates
Inc
Oct252007
Unknown
Masland
Associates
Inc
Oct182007
Masland
Associates
Inc
Oct082007
Unknown
Masland
Associates
Inc
Oct032007
(chief complaint)
Masland
Associates
Inc
Sep172007
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Aug232007
Masland
Associates
Inc
Aug062007
Unknown
Masland
Associates
Inc
Jul172007
Masland
Associates
Inc
Jul162007
Unknown
Masland
Associates
Inc
Jul112007
Masland
Associates
Inc
Jun282007
Masland
Associates
Inc
Jun252007
Masland
Associates
Inc
Jun042007
Unknown
Masland
Associates
Inc
May292007
Masland
Associates
Inc
May212007
Masland
Associates
Inc
May072007
Masland
Associates
Inc
Apr232007
Unknown
Masland
Associates
Inc
Apr112007
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Apr092007
Masland
Associates
Inc
Mar302007
Masland
Associates
Inc
Mar262007
Masland
Associates
Inc
Mar232007
Masland
Associates
Inc
Mar152007
Office consultation,
New/Est Mod-high Sev
Masland
Associates
Inc
Feb282007
Unknown
Masland
Associates
Inc
Feb152007
Masland
Associates
Inc
Feb092007
Masland
Associates
Inc
Jan302007
Masland
Associates
Inc
Jan222007
Masland
Associates
Inc
Jan052007
Masland
Associates
Inc
Jan022007
Masland
Associates
Inc
Dec112006
Masland
Associates
Inc
Nov202006
Masland
Associates
Inc
Oct302006
Masland
Associates
Inc
Oct232006
Masland
Associates
Inc
Oct092006
Unknown
Masland
Associates
Inc
Sep252006
Masland
Associates
Inc
Sep222006
Masland
Associates
Inc
Sep182006
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Sep142006
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Sep012006
Masland
Aug-
Associates
Inc
282006
Masland
Associates
Inc
Aug072006
Masland
Associates
Inc
Jul252006
Masland
Associates
Inc
Jul172006
Masland
Associates
Inc
Jun262006
Masland
Associates
Inc
Jun192006
Masland
Associates
Inc
Jun052006
Masland
Associates
Inc
May232006
Masland
Associates
Inc
May222006
Masland
Associates
Inc
May152006
Masland
Associates
Inc
May082006
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
May012006
Masland
Associates
Inc
Apr242006
Masland
Associates
Inc
Apr212006
Masland
Associates
Inc
Apr142006
Masland
Associates
Inc
Mar132006
Unknown
Masland
Associates
Inc
Mar092006
Masland
Associates
Inc
Mar012006
Masland
Associates
Inc
Feb232006
Masland
Associates
Feb22-
Inc
2006
7172491929
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Feb172006
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Feb162006
Masland
Associates
Inc
Feb152006
Unknown
CRMC
Feb132006
Masland
Associates
Inc
Feb132006
Masland
Associates
Inc
Feb082006
Level Three Est Patient Masland Associates Inc, 220 Wilson StreetSuite 109,
Carlisle, PA, 170133650 tel:+1-7172491929
Masland
Associates
Inc
Feb072006
Masland
Associates
Inc
Feb012006
Masland
Associates
Inc
Jan252006
Masland
Associates
Inc
Jan202006
Family History
Family Member
Diagnosis
Age At Onset
Status
Father
Myocardial infarction
73
Yes
(Unknown)
Mother
Rheumatic Fever
78
Immunizations
Vaccine
Date
Status
Comments
Sep-24-2013
completed
Aug-13-2013
completed
Tdap (Boostrix r)
Dec-12-2012
completed
Nov-15-2012
completed
Aug-26-2011
completed
Sep-30-2010
completed
Oct-13-2008
completed
Zoster
Feb-08-2008
completed
Oct-25-2007
completed
Yes
Oct-23-2006
completed
Payers
Payer name
Insurance type
Covered party ID
BL
FER115161532001
Medicare
MB
CI
BL
Blue Cross
BL
Authorization(s)
Social History
Type
Description
Quantity
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Date
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Smoking Status
Never smoker
Vital Signs
Date / Time:
Height
Weight
BMI
Pulse Rate
Jul-24-2014/08:18:00
58.00 in
145.00 lbs
30.30
70 /min
Jun-12-2014/10:40:00
58.00 in
146.00 lbs
30.51
82 /min
Apr-14-2014/13:19:00
58.00 in
146.00 lbs
30.51
Dec-27-2013/13:15:00
58.00 in
146.50 lbs
Aug-13-2013/09:54:00
58.00 in
Apr-19-2013/14:08:00
Temperature
Respiratory Rate
96.0 F
16 /min
140/76 mm[Hg]
95.9 F
16 /min
78 /min
136/84 mm[Hg]
98.8 F
30 /min
30.62
60 /min
130/80 mm[Hg]
96.5 F
14 /min
144.00 lbs
30.09
64 /min
144/82 mm[Hg]
96.8 F
12 /min
58.00 in
149.00 lbs
31.14
72 /min
124/76 mm[Hg]
96.4 F
18 /min
Mar-12-2013/13:09:00
58.00 in
149.00 lbs
31.14
64 /min
120/70 mm[Hg]
96.2 F
Feb-12-2013/11:00:00
57.75 in
147.00 lbs
30.99
80 /min
120/72 mm[Hg]
96.9 F
60 /min
136/82 mm[Hg]
80 /min
140/80 mm[Hg]
96.5 F
Dec-12-2012/14:03:00
Nov-15-2012/13:30:00
57.75 in
147.50 lbs
31.09
Blood Pressure
Oct-18-2012/15:31:00
146.00 lbs
88 /min
136/62 mm[Hg]
99.8 F
Jul-12-2012/13:01:00
146.00 lbs
60 /min
150/86 mm[Hg]
96.4 F
May-30-2012/13:18:00
146.00 lbs
72 /min
132/70 mm[Hg]
96.8 F
Apr-23-2012/10:11:00
145.00 lbs
56 /min
162/94 mm[Hg]
95.5 F
Mar-08-2012/13:57:00
149.00 lbs
60 /min
126/68 mm[Hg]
98.1 F
Jan-12-2012/14:05:00
148.00 lbs
66 /min
120/76 mm[Hg]
96.5 F
Dec-27-2011/15:04:00
153.00 lbs
68 /min
126/80 mm[Hg]
97.6 F
Dec-09-2011/10:41:00
154.00 lbs
80 /min
142/94 mm[Hg]
95.6 F
Dec-06-2011/11:30:00
154.00 lbs
80 /min
132/80 mm[Hg]
97.5 F
Nov-17-2011/11:29:00
58.00 in
153.00 lbs
31.97
66 /min
128/80 mm[Hg]
94.0 F
Aug-26-2011/09:58:00
58.00 in
154.00 lbs
32.18
72 /min
132/74 mm[Hg]
96.1 F
80 /min
138/86 mm[Hg]
95.8 F
76 /min
134/80 mm[Hg]
80 /min
166/92 mm[Hg]
86 /min
158/86 mm[Hg]
96.6 F
Feb-24-2011/13:15:00
Sep-30-2010/11:31:00
158.00 lbs
57.30 in
Sep-23-2010/13:23:00
157.00 lbs
33.62
158.00 lbs
Sep-23-2010/13:25:00
May-26-2010/14:23:00
154.50 lbs
88 /min
132/74 mm[Hg]
98.2 F
May-13-2010/14:07:00
157.00 lbs
66 /min
142/80 mm[Hg]
97.2 F
78 /min
126/72 mm[Hg]
96.8 F
Apr-12-2010/09:55:00
58.00 in
155.00 lbs
32.39
Mar-23-2010/14:49:00
159.00 lbs
92 /min
136/88 mm[Hg]
95.6 F
Dec-14-2009/10:16:00
155.00 lbs
62 /min
140/90 mm[Hg]
97.1 F
Head Circumference
BMI percentile
Jul-06-2009/14:23:00
156.00 lbs
72 /min
126/88 mm[Hg]
97.6 F
Jun-08-2009/09:49:00
155.50 lbs
74 /min
126/78 mm[Hg]
97.7 F
Jan-12-2009/13:11:00
158.00 lbs
64 /min
132/80 mm[Hg]
96.7 F
Sep-03-2008/09:41:00
153.00 lbs
66 /min
130/78 mm[Hg]
97.7 F
Aug-15-2008/11:31:00
154.00 lbs
80 /min
128/70 mm[Hg]
96.3 F
Jul-31-2008/15:42:00
152.00 lbs
88 /min
124/80 mm[Hg]
98.1 F
68 /min
136/84 mm[Hg]
95.2 F
May-12-2008/10:30:00
58.50 in
149.00 lbs
30.61
Apr-04-2008/10:54:00
150.00 lbs
76 /min
116/80 mm[Hg]
Mar-20-2008/13:57:00
150.00 lbs
66 /min
124/84 mm[Hg]
97.0 F
76 /min
142/66 mm[Hg]
96.5 F
Feb-08-2008/14:42:00
57.50 in
148.00 lbs
31.47
Dec-28-2007/10:24:00
147.50 lbs
66 /min
122/88 mm[Hg]
96.2 F
Nov-27-2007/11:14:00
145.00 lbs
78 /min
136/88 mm[Hg]
96.5 F
Aug-23-2007/10:33:00
142.50 lbs
66 /min
134/80 mm[Hg]
96.5 F
Jun-28-2007/11:10:00
139.00 lbs
82 /min
144/90 mm[Hg]
96.8 F
Apr-09-2007/14:05:00
138.80 lbs
84 /min
134/80 mm[Hg]
96.8 F
Feb-28-2007/08:15:00
138.00 lbs
72 /min
134/80 mm[Hg]
95.6 F
Jan-30-2007/14:06:00
136.00 lbs
130/80 mm[Hg]
97.6 F
Sep-22-2006/16:13:00
128.00 lbs
94 /min
128/84 mm[Hg]
97.2 F
Sep-14-2006/14:01:00
129.00 lbs
88 /min
132/80 mm[Hg]
96.8 F
Sep-01-2006/14:50:00
129.50 lbs
88 /min
130/74 mm[Hg]
97.5 F
88 /min
148/84 mm[Hg]
95.5 F
Jul-25-2006/11:34:00
Chief Complaint
Plan Of Care
Date
Type
Action
Status
10/20/2014 13:30
Appointment
Allison, Sherry
BOOKED
Sep-23-2014
INR
Ordered
Functional Status
Encounter Date
Functional Assessment
Jul-24-2014
N/A
Cognitive Assessment
Jun-12-2014
N/A
Apr-14-2014
N/A
Dec-27-2013
N/A
Aug-13-2013
N/A
Apr-19-2013
N/A
Mar-12-2013
N/A
Feb-12-2013
N/A
Nov-15-2012
N/A
Oct-18-2012
N/A
Jul-12-2012
N/A
Apr-23-2012
N/A
Mar-08-2012
N/A
Jan-12-2012
N/A
Dec-27-2011
N/A
Nov-17-2011
N/A
Aug-26-2011
N/A
Feb-24-2011
N/A
Sep-30-2010
N/A
Sep-23-2010
N/A
Apr-12-2010
N/A
Dec-14-2009
N/A
Jun-08-2009
N/A
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Jan-12-2009
N/A
Sep-03-2008
N/A
May-12-2008
N/A
Mar-20-2008
N/A
Feb-08-2008
N/A
Dec-28-2007
N/A
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Normal Orientation
Medications Administered
Medication
Instructions
Dosage
Status
88 MCG
Apr-10-2013 - Apr-10-2013
No Longer Active
12.5 MG
Jan-11-2013 - Jan-11-2013
No Longer Active
warfarin 5 mg Tab
5 MG
Nov-15-2012 - Nov-15-2012
No Longer Active
88 MCG
Apr-20-2012 - Apr-20-2012
No Longer Active
FOLTX 1-2.5-25MGTABLET
Oct-22-2009 - Oct-22-2009
No Longer Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-12-2009
No Longer Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-12-2009
No Longer Active
Actonel 75 mg Tab
2 monthly
Jan-12-2009 - Jan-12-2009
No Longer Active
warfarin 2 mg Tab
as dir/4mg daily
Apr-04-2008 - Apr-04-2008
No Longer Active
Coumadin 4 mg Tab
Take as directed
Nov-27-2007 - Nov-27-2007
No Longer Active
Aricept 5 mg Tab
Jul-11-2007 - Jul-11-2007
No Longer Active
Instructions
Date
Unknown
Instruction
Additional Information
Comments